Advanced Search (OLGA)

Gene: ZCCHC14 (zinc finger CCHC-type containing 14) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

ZCCHC14

Name:

zinc finger CCHC-type containing 14

RGD ID:

1349569

HGNC Page

HGNC:24134

Description:

Predicted to enable nucleic acid binding activity; phosphatidylinositol binding activity; and zinc ion binding activity.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

BDG-29; BDG29; MGC126527; MGC14139; zinc finger CCHC domain-containing protein 14; zinc finger, CCHC domain containing 14

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	16	87,406,248 - 87,493,024 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	16	87,406,246 - 87,493,024 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	16	87,439,854 - 87,526,630 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	16	85,997,353 - 86,082,961 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	16	85,997,363 - 86,082,966	NCBI
Celera	16	71,736,619 - 71,822,230 (-)	NCBI		Celera
Cytogenetic Map	16	q24.2	NCBI
HuRef	16	73,182,266 - 73,267,848 (-)	NCBI		HuRef
CHM1_1	16	88,851,639 - 88,937,191 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	16	93,477,129 - 93,563,941 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
ZCCHC14	Human	16Q24.3 Microdeletion Syndrome		IAGP	(Homo sapiens) and (Homo sapiens)	8554872	ClinVar Annotator: match by term: 16q24.3 microdeletion syndrome	ClinVar
ZCCHC14	Human	KBG syndrome		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: KBG syndrome	ClinVar	PMID:31690835
ZCCHC14	Human	persistent fetal circulation syndrome		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Congenital alveolar capillary dysplasia	ClinVar

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
ZCCHC14	Human	Stroke		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:29531354

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
ZCCHC14	Human	1,2-dichloroethane	decreases expression	ISO	Zcchc14 (Mus musculus)	6480464	ethylene dichloride results in decreased expression of ZCCHC14 mRNA	CTD	PMID:28960355
ZCCHC14	Human	1,2-dimethylhydrazine	increases expression	ISO	Zcchc14 (Mus musculus)	6480464	1 and 2-Dimethylhydrazine results in increased expression of ZCCHC14 mRNA	CTD	PMID:22206623
ZCCHC14	Human	17alpha-ethynylestradiol	increases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	Ethinyl Estradiol results in increased expression of ZCCHC14 mRNA	CTD	PMID:29097150
ZCCHC14	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Progesterone co-treated with Estradiol] results in decreased expression of ZCCHC14 mRNA	CTD	PMID:17404688
ZCCHC14	Human	17beta-estradiol	decreases expression	ISO	Zcchc14 (Mus musculus)	6480464	Estradiol results in decreased expression of ZCCHC14 mRNA	CTD	PMID:39298647
ZCCHC14	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	Zcchc14 (Mus musculus)	6480464	Tetrachlorodibenzodioxin affects the expression of ZCCHC14 mRNA	CTD	PMID:21570461
ZCCHC14	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in decreased expression of ZCCHC14 mRNA	CTD	PMID:33387578
ZCCHC14	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in increased expression of ZCCHC14 mRNA	CTD	PMID:32109520
ZCCHC14	Human	2-methylcholine	affects expression	EXP		6480464	beta-methylcholine affects the expression of ZCCHC14 mRNA	CTD	PMID:21179406
ZCCHC14	Human	4,4'-sulfonyldiphenol	decreases expression	ISO	Zcchc14 (Mus musculus)	6480464	bisphenol S results in decreased expression of ZCCHC14 mRNA	CTD	PMID:39298647
ZCCHC14	Human	4,4'-sulfonyldiphenol	decreases methylation	EXP		6480464	bisphenol S results in decreased methylation of ZCCHC14 gene	CTD	PMID:31601247
ZCCHC14	Human	acrylamide	decreases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	Acrylamide results in decreased expression of ZCCHC14 mRNA	CTD	PMID:28959563
ZCCHC14	Human	aflatoxin B1	decreases methylation	EXP		6480464	Aflatoxin B1 results in decreased methylation of ZCCHC14 gene	CTD	PMID:27153756
ZCCHC14	Human	all-trans-retinoic acid	increases expression	EXP		6480464	Tretinoin results in increased expression of ZCCHC14 mRNA	CTD	PMID:23724009
ZCCHC14	Human	all-trans-retinoic acid	decreases expression	EXP		6480464	Tretinoin results in decreased expression of ZCCHC14 mRNA	CTD	PMID:33167477
ZCCHC14	Human	antirheumatic drug	decreases expression	EXP		6480464	Antirheumatic Agents results in decreased expression of ZCCHC14 mRNA	CTD	PMID:24449571
ZCCHC14	Human	arsane	affects methylation	EXP		6480464	Arsenic affects the methylation of ZCCHC14 gene	CTD	PMID:25304211
ZCCHC14	Human	arsenic atom	affects methylation	EXP		6480464	Arsenic affects the methylation of ZCCHC14 gene	CTD	PMID:25304211
ZCCHC14	Human	arsenite(3-)	multiple interactions	EXP		6480464	arsenite inhibits the reaction [G3BP1 protein binds to ZCCHC14 mRNA]	CTD	PMID:32406909
ZCCHC14	Human	benzene	increases expression	EXP		6480464	Benzene results in increased expression of ZCCHC14 mRNA	CTD	PMID:19162166
ZCCHC14	Human	benzo[a]pyrene	multiple interactions	ISO	Zcchc14 (Mus musculus)	6480464	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ZCCHC14 mRNA]	CTD	PMID:22228805
ZCCHC14	Human	benzo[a]pyrene	increases methylation	EXP		6480464	Benzo(a)pyrene results in increased methylation of ZCCHC14 3' UTR	CTD	PMID:27901495
ZCCHC14	Human	benzo[a]pyrene	decreases expression	EXP		6480464	Benzo(a)pyrene results in decreased expression of ZCCHC14 mRNA	CTD	PMID:26238291
ZCCHC14	Human	benzo[a]pyrene diol epoxide I	decreases expression	EXP		6480464	7 more ...	CTD	PMID:19150397
ZCCHC14	Human	Benzo[k]fluoranthene	decreases expression	ISO	Zcchc14 (Mus musculus)	6480464	benzo(k)fluoranthene results in decreased expression of ZCCHC14 mRNA	CTD	PMID:26377693
ZCCHC14	Human	bis(2-ethylhexyl) phthalate	increases expression	ISO	Zcchc14 (Mus musculus)	6480464	Diethylhexyl Phthalate results in increased expression of ZCCHC14 mRNA	CTD	PMID:34319233
ZCCHC14	Human	bisphenol A	decreases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	bisphenol A results in decreased expression of ZCCHC14 mRNA	CTD	PMID:25181051 and PMID:32528016
ZCCHC14	Human	bisphenol A	decreases methylation	EXP		6480464	bisphenol A results in decreased methylation of ZCCHC14 gene	CTD	PMID:31601247
ZCCHC14	Human	bisphenol A	increases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	bisphenol A results in increased expression of ZCCHC14 mRNA	CTD	PMID:34947998 and PMID:38750585
ZCCHC14	Human	bisphenol A	affects expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	bisphenol A affects the expression of ZCCHC14 mRNA	CTD	PMID:30816183
ZCCHC14	Human	bisphenol A	increases methylation	ISO	Zcchc14 (Mus musculus)	6480464	bisphenol A results in increased methylation of ZCCHC14 promoter	CTD	PMID:27312807
ZCCHC14	Human	cadmium dichloride	increases expression	EXP		6480464	Cadmium Chloride results in increased expression of ZCCHC14 mRNA	CTD	PMID:38382870
ZCCHC14	Human	carbamazepine	affects expression	EXP		6480464	Carbamazepine affects the expression of ZCCHC14 mRNA	CTD	PMID:25979313
ZCCHC14	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to ZCCHC14 gene]	CTD	PMID:28238834
ZCCHC14	Human	choline	multiple interactions	ISO	Zcchc14 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ZCCHC14 mRNA	CTD	PMID:20938992
ZCCHC14	Human	clobetasol	decreases expression	ISO	Zcchc14 (Mus musculus)	6480464	Clobetasol results in decreased expression of ZCCHC14 mRNA	CTD	PMID:27462272
ZCCHC14	Human	copper(II) sulfate	decreases expression	EXP		6480464	Copper Sulfate results in decreased expression of ZCCHC14 mRNA	CTD	PMID:19549813
ZCCHC14	Human	crocidolite asbestos	decreases expression	ISO	Zcchc14 (Mus musculus)	6480464	Asbestos and Crocidolite results in decreased expression of ZCCHC14 mRNA	CTD	PMID:29279043
ZCCHC14	Human	Cuprizon	increases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	Cuprizone results in increased expression of ZCCHC14 mRNA	CTD	PMID:27523638
ZCCHC14	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of ZCCHC14 mRNA	CTD	PMID:25562108
ZCCHC14	Human	dicrotophos	increases expression	EXP		6480464	dicrotophos results in increased expression of ZCCHC14 mRNA	CTD	PMID:28302478
ZCCHC14	Human	doxorubicin	increases expression	EXP		6480464	Doxorubicin results in increased expression of ZCCHC14 mRNA	CTD	PMID:29803840
ZCCHC14	Human	epoxiconazole	decreases expression	ISO	Zcchc14 (Mus musculus)	6480464	epoxiconazole results in decreased expression of ZCCHC14 mRNA	CTD	PMID:35436446
ZCCHC14	Human	ethanol	affects splicing	ISO	Zcchc14 (Mus musculus)	6480464	Ethanol affects the splicing of ZCCHC14 mRNA	CTD	PMID:30319688
ZCCHC14	Human	folic acid	multiple interactions	ISO	Zcchc14 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ZCCHC14 mRNA	CTD	PMID:20938992
ZCCHC14	Human	formaldehyde	decreases expression	EXP		6480464	Formaldehyde results in decreased expression of ZCCHC14 mRNA	CTD	PMID:20655997
ZCCHC14	Human	formaldehyde	increases expression	EXP		6480464	Formaldehyde results in increased expression of ZCCHC14 mRNA	CTD	PMID:23649840
ZCCHC14	Human	gentamycin	decreases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	Gentamicins results in decreased expression of ZCCHC14 mRNA	CTD	PMID:33387578
ZCCHC14	Human	hydrogen peroxide	affects expression	EXP		6480464	Hydrogen Peroxide affects the expression of ZCCHC14 mRNA	CTD	PMID:21179406
ZCCHC14	Human	iron dichloride	decreases expression	EXP		6480464	ferrous chloride results in decreased expression of ZCCHC14 mRNA	CTD	PMID:35984750
ZCCHC14	Human	L-methionine	multiple interactions	ISO	Zcchc14 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ZCCHC14 mRNA	CTD	PMID:20938992
ZCCHC14	Human	menadione	affects expression	EXP		6480464	Vitamin K 3 affects the expression of ZCCHC14 mRNA	CTD	PMID:20044591
ZCCHC14	Human	nickel sulfate	increases expression	EXP		6480464	nickel sulfate results in increased expression of ZCCHC14 mRNA	CTD	PMID:22714537
ZCCHC14	Human	paracetamol	increases expression	EXP		6480464	Acetaminophen results in increased expression of ZCCHC14 mRNA	CTD	PMID:29067470
ZCCHC14	Human	paracetamol	increases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	Acetaminophen results in increased expression of ZCCHC14 mRNA	CTD	PMID:33387578
ZCCHC14	Human	phenobarbital	affects expression	ISO	Zcchc14 (Mus musculus)	6480464	Phenobarbital affects the expression of ZCCHC14 mRNA	CTD	PMID:23091169
ZCCHC14	Human	progesterone	multiple interactions	EXP		6480464	[Progesterone co-treated with Estradiol] results in decreased expression of ZCCHC14 mRNA	CTD	PMID:17404688
ZCCHC14	Human	quercitrin	increases expression	EXP		6480464	quercitrin results in increased expression of ZCCHC14 mRNA	CTD	PMID:25193878
ZCCHC14	Human	silicon dioxide	decreases expression	EXP		6480464	Silicon Dioxide results in decreased expression of ZCCHC14 mRNA	CTD	PMID:25351596
ZCCHC14	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of ZCCHC14 mRNA	CTD	PMID:25879800
ZCCHC14	Human	thioacetamide	increases expression	ISO	Zcchc14 (Rattus norvegicus)	6480464	Thioacetamide results in increased expression of ZCCHC14 mRNA	CTD	PMID:34492290
ZCCHC14	Human	thiram	increases expression	EXP		6480464	Thiram results in increased expression of ZCCHC14 mRNA	CTD	PMID:38568856
ZCCHC14	Human	titanium dioxide	decreases methylation	ISO	Zcchc14 (Mus musculus)	6480464	titanium dioxide results in decreased methylation of ZCCHC14 promoter	CTD	PMID:35295148
ZCCHC14	Human	trichostatin A	affects expression	EXP		6480464	trichostatin A affects the expression of ZCCHC14 mRNA	CTD	PMID:28542535
ZCCHC14	Human	triphenyl phosphate	affects expression	EXP		6480464	triphenyl phosphate affects the expression of ZCCHC14 mRNA	CTD	PMID:37042841
ZCCHC14	Human	troglitazone	decreases expression	ISO	Zcchc14 (Mus musculus)	6480464	troglitazone results in decreased expression of ZCCHC14 mRNA	CTD	PMID:28973697
ZCCHC14	Human	urethane	increases expression	EXP		6480464	Urethane results in increased expression of ZCCHC14 mRNA	CTD	PMID:28818685
ZCCHC14	Human	valproic acid	increases methylation	EXP		6480464	Valproic Acid results in increased methylation of ZCCHC14 gene	CTD	PMID:29154799
ZCCHC14	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of ZCCHC14 mRNA	CTD	PMID:37505509

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
ZCCHC14	Human	metal ion binding	enables	IEA	UniProtKB-KW:KW-0479	150520179		UniProt	GO_REF:0000043
ZCCHC14	Human	nucleic acid binding	enables	IEA	InterPro:IPR001878 and InterPro:IPR036875	150520179		InterPro	GO_REF:0000002
ZCCHC14	Human	phosphatidylinositol binding	enables	IEA	InterPro:IPR036871	150520179		InterPro	GO_REF:0000002
ZCCHC14	Human	protein binding	enables	IPI	UniProtKB:A8MQ03 more ...	150520179	PMID:32296183	IntAct	PMID:32296183
ZCCHC14	Human	zinc ion binding	enables	IEA	InterPro:IPR001878 and InterPro:IPR036875	150520179		InterPro	GO_REF:0000002
ZCCHC14	Human	zinc ion binding	enables	IEA	UniProtKB-KW:KW-0863	150520179		UniProt	GO_REF:0000043

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
3.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
4.	Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.	Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.

PMID:9628581	PMID:12168954	PMID:15146197	PMID:16189514	PMID:16344560	PMID:19322201	PMID:19460752	PMID:21988832	PMID:22472876	PMID:23824909	PMID:26186194	PMID:26496610
PMID:26972000	PMID:27609421	PMID:27997041	PMID:28700943	PMID:29395067	PMID:29507755	PMID:30404004	PMID:31646585	PMID:31801065	PMID:32296183	PMID:32451488	PMID:33345444
PMID:33961781	PMID:34079125	PMID:34373451	PMID:34535262	PMID:34672954	PMID:35748872	PMID:35867748	PMID:36804426	PMID:36931259	PMID:38334954	PMID:38501662	PMID:38803224
PMID:39098523

ZCCHC14
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	16	87,406,248 - 87,493,024 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	16	87,406,246 - 87,493,024 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	16	87,439,854 - 87,526,630 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	16	85,997,353 - 86,082,961 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	16	85,997,363 - 86,082,966	NCBI
Celera	16	71,736,619 - 71,822,230 (-)	NCBI		Celera
Cytogenetic Map	16	q24.2	NCBI
HuRef	16	73,182,266 - 73,267,848 (-)	NCBI		HuRef
CHM1_1	16	88,851,639 - 88,937,191 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	16	93,477,129 - 93,563,941 (-)	NCBI		T2T-CHM13v2.0

Zcchc14
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	8	122,325,442 - 122,379,662 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	8	122,325,442 - 122,379,640 (-)	Ensembl		GRCm39 Ensembl
GRCm38	8	121,598,697 - 121,652,791 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	8	121,598,703 - 121,652,901 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	8	124,122,603 - 124,175,833 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	8	124,485,528 - 124,538,023 (-)	NCBI		MGSCv36	mm8
Celera	8	125,820,046 - 125,873,474 (-)	NCBI		Celera
Cytogenetic Map	8	E1	NCBI
cM Map	8	70.67	NCBI

Zcchc14
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	19	66,582,800 - 66,627,136 (-)	NCBI		GRCr8
mRatBN7.2	19	49,674,185 - 49,718,004 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	19	49,674,195 - 49,718,029 (-)	Ensembl		mRatBN7.2 Ensembl
Rnor_6.0	19	53,644,500 - 53,688,624 (-)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	19	53,647,815 - 53,688,597 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	19	64,381,938 - 64,426,070 (-)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	19	51,858,907 - 51,899,663 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	19	51,863,747 - 51,904,544 (-)	NCBI
Celera	19	48,921,002 - 48,964,690 (-)	NCBI		Celera
Cytogenetic Map	19	q12	NCBI

Zcchc14
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955541	1,872,624 - 1,909,779 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955541	1,872,624 - 1,909,723 (-)	NCBI	ChiLan1.0	ChiLan1.0

ZCCHC14
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	18	97,165,154 - 97,251,845 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	16	103,079,289 - 103,168,696 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	16	68,078,237 - 68,165,406 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	16	87,401,184 - 87,486,124 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	16	87,401,184 - 87,486,124 (-)	Ensembl	panpan1.1		panPan2

ZCCHC14
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	5	65,611,032 - 65,667,162 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	5	65,611,026 - 65,664,923 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	5	65,622,560 - 65,679,884 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	5	65,832,428 - 65,889,740 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	5	65,830,308 - 65,887,136 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	5	65,857,317 - 65,914,597 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	5	65,689,172 - 65,746,484 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	5	66,103,133 - 66,160,629 (+)	NCBI		UU_Cfam_GSD_1.0

Zcchc14
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024409349	25,975,048 - 26,030,891 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936641	1,728,592 - 1,781,896 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936641	1,728,596 - 1,783,710 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

ZCCHC14
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	6	1,850,051 - 1,918,704 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	6	1,849,974 - 1,917,601 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	6	1,937,818 - 2,005,535 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

ZCCHC14
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	5	72,776,249 - 72,863,957 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	5	72,780,300 - 72,863,860 (-)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666047	2,832,207 - 2,920,201 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Zcchc14
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624746	3,097,565 - 3,138,799 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624746	3,096,644 - 3,138,825 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in ZCCHC14
112 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 16q23.1-24.3(chr16:78816291-90081985)x3	copy number gain	See cases [RCV000050840]	Chr16:78816291..90081985 [GRCh38] Chr16:78850188..90148393 [GRCh37] Chr16:77407689..88675894 [NCBI36] Chr16:16q23.1-24.3	pathogenic
GRCh38/hg38 16q22.1-24.3(chr16:70514631-90081985)x3	copy number gain	See cases [RCV000052422]	Chr16:70514631..90081985 [GRCh38] Chr16:70548534..90148393 [GRCh37] Chr16:69106035..88675894 [NCBI36] Chr16:16q22.1-24.3	pathogenic
GRCh38/hg38 16q21-24.3(chr16:65313395-90081985)x3	copy number gain	See cases [RCV000052421]	Chr16:65313395..90081985 [GRCh38] Chr16:65347298..90148393 [GRCh37] Chr16:63904799..88675894 [NCBI36] Chr16:16q21-24.3	pathogenic
GRCh38/hg38 16q23.1-24.3(chr16:76873569-90081985)x3	copy number gain	See cases [RCV000052423]	Chr16:76873569..90081985 [GRCh38] Chr16:76907466..90148393 [GRCh37] Chr16:75464967..88675894 [NCBI36] Chr16:16q23.1-24.3	pathogenic
GRCh38/hg38 16q23.3-24.3(chr16:82173150-90081985)x3	copy number gain	See cases [RCV000052424]	Chr16:82173150..90081985 [GRCh38] Chr16:82206755..90148393 [GRCh37] Chr16:80764256..88675894 [NCBI36] Chr16:16q23.3-24.3	pathogenic
GRCh38/hg38 16q24.1-24.3(chr16:84707538-90081985)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052425]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052425]\|See cases [RCV000052425]	Chr16:84707538..90081985 [GRCh38] Chr16:84741144..90148393 [GRCh37] Chr16:83298645..88675894 [NCBI36] Chr16:16q24.1-24.3	pathogenic
GRCh38/hg38 16q23.1-24.2(chr16:78704275-87819342)x1	copy number loss	See cases [RCV000053359]	Chr16:78704275..87819342 [GRCh38] Chr16:78738172..87852948 [GRCh37] Chr16:77295673..86410449 [NCBI36] Chr16:16q23.1-24.2	pathogenic
GRCh38/hg38 16q24.2-24.3(chr16:87306529-89269079)x1	copy number loss	See cases [RCV000053362]	Chr16:87306529..89269079 [GRCh38] Chr16:87340135..89335487 [GRCh37] Chr16:85897636..87862988 [NCBI36] Chr16:16q24.2-24.3	pathogenic
NM_015144.2(ZCCHC14):c.2817C>T (p.Ala939=)	single nucleotide variant	Malignant melanoma [RCV000071265]	Chr16:87410313 [GRCh38] Chr16:87443919 [GRCh37] Chr16:86001420 [NCBI36] Chr16:16q24.2	not provided
GRCh38/hg38 16q24.1-24.2(chr16:86672163-87766879)x1	copy number loss	See cases [RCV000134960]	Chr16:86672163..87766879 [GRCh38] Chr16:86705769..87800485 [GRCh37] Chr16:85263270..86357986 [NCBI36] Chr16:16q24.1-24.2	likely pathogenic
GRCh38/hg38 16q23.3-24.3(chr16:83988570-90081985)x3	copy number gain	See cases [RCV000135659]	Chr16:83988570..90081985 [GRCh38] Chr16:84022175..90148393 [GRCh37] Chr16:82579676..88675894 [NCBI36] Chr16:16q23.3-24.3	likely pathogenic
GRCh38/hg38 16q24.2(chr16:87223779-87853460)x1	copy number loss	See cases [RCV000135624]	Chr16:87223779..87853460 [GRCh38] Chr16:87257385..87887066 [GRCh37] Chr16:85814886..86444567 [NCBI36] Chr16:16q24.2	uncertain significance
GRCh38/hg38 16q24.2(chr16:87150123-87812135)x1	copy number loss	See cases [RCV000135595]	Chr16:87150123..87812135 [GRCh38] Chr16:87183729..87845741 [GRCh37] Chr16:85741230..86403242 [NCBI36] Chr16:16q24.2	likely pathogenic\|uncertain significance
GRCh38/hg38 16q24.2(chr16:87223779-87440975)x1	copy number loss	See cases [RCV000136537]	Chr16:87223779..87440975 [GRCh38] Chr16:87257385..87474581 [GRCh37] Chr16:85814886..86032082 [NCBI36] Chr16:16q24.2	uncertain significance
GRCh38/hg38 16q23.2-24.3(chr16:80946659-90081985)x3	copy number gain	See cases [RCV000136898]	Chr16:80946659..90081985 [GRCh38] Chr16:80980556..90148393 [GRCh37] Chr16:79538057..88675894 [NCBI36] Chr16:16q23.2-24.3	pathogenic\|likely pathogenic
GRCh38/hg38 16q22.1-24.3(chr16:70749398-90096995)x3	copy number gain	See cases [RCV000137495]	Chr16:70749398..90096995 [GRCh38] Chr16:70783301..90163403 [GRCh37] Chr16:69340802..88690904 [NCBI36] Chr16:16q22.1-24.3	pathogenic
GRCh38/hg38 16q23.3-24.3(chr16:83478453-89932910)x3	copy number gain	See cases [RCV000137980]	Chr16:83478453..89932910 [GRCh38] Chr16:83512058..89999318 [GRCh37] Chr16:82069559..88526819 [NCBI36] Chr16:16q23.3-24.3	likely pathogenic
GRCh38/hg38 16q21-24.3(chr16:65511483-90096995)x3	copy number gain	See cases [RCV000139426]	Chr16:65511483..90096995 [GRCh38] Chr16:65545386..90163403 [GRCh37] Chr16:64102887..88690904 [NCBI36] Chr16:16q21-24.3	pathogenic
GRCh38/hg38 16q23.1-24.3(chr16:75377981-90081992)x3	copy number gain	See cases [RCV000139302]	Chr16:75377981..90081992 [GRCh38] Chr16:75411879..90148400 [GRCh37] Chr16:73969380..88675901 [NCBI36] Chr16:16q23.1-24.3	pathogenic
GRCh38/hg38 16q24.1-24.3(chr16:85552976-90096995)x3	copy number gain	See cases [RCV000139658]	Chr16:85552976..90096995 [GRCh38] Chr16:85586582..90163403 [GRCh37] Chr16:84144083..88690904 [NCBI36] Chr16:16q24.1-24.3	pathogenic
GRCh38/hg38 16q24.2(chr16:87038922-87766879)x1	copy number loss	See cases [RCV000139802]	Chr16:87038922..87766879 [GRCh38] Chr16:87072528..87800485 [GRCh37] Chr16:85630029..86357986 [NCBI36] Chr16:16q24.2	uncertain significance
GRCh38/hg38 16q23.2-24.3(chr16:80717291-90096662)x3	copy number gain	See cases [RCV000141128]	Chr16:80717291..90096662 [GRCh38] Chr16:80751188..90163070 [GRCh37] Chr16:79308689..88690571 [NCBI36] Chr16:16q23.2-24.3	pathogenic
GRCh38/hg38 16q23.1-24.3(chr16:76336203-90088654)x3	copy number gain	See cases [RCV000141700]	Chr16:76336203..90088654 [GRCh38] Chr16:76370100..90155062 [GRCh37] Chr16:74927601..88682563 [NCBI36] Chr16:16q23.1-24.3	pathogenic
GRCh38/hg38 16q21-24.3(chr16:64389378-90081985)x3	copy number gain	See cases [RCV000142578]	Chr16:64389378..90081985 [GRCh38] Chr16:64423281..90148393 [GRCh37] Chr16:62980782..88675894 [NCBI36] Chr16:16q21-24.3	pathogenic\|likely pathogenic
GRCh38/hg38 16q23.2-24.3(chr16:80067315-90057871)x3	copy number gain	See cases [RCV000142698]	Chr16:80067315..90057871 [GRCh38] Chr16:80101212..90124279 [GRCh37] Chr16:78658713..88651780 [NCBI36] Chr16:16q23.2-24.3	pathogenic
GRCh38/hg38 16q24.2(chr16:87382052-87766879)x1	copy number loss	See cases [RCV000142722]	Chr16:87382052..87766879 [GRCh38] Chr16:87415658..87800485 [GRCh37] Chr16:85973159..86357986 [NCBI36] Chr16:16q24.2	likely pathogenic\|uncertain significance
GRCh38/hg38 16q12.2-24.3(chr16:52899183-90088654)x3	copy number gain	See cases [RCV000143425]	Chr16:52899183..90088654 [GRCh38] Chr16:52933095..90155062 [GRCh37] Chr16:51490596..88682563 [NCBI36] Chr16:16q12.2-24.3	pathogenic
GRCh38/hg38 16q24.1-24.3(chr16:86950106-89335814)x1	copy number loss	See cases [RCV000143624]	Chr16:86950106..89335814 [GRCh38] Chr16:86983712..89402222 [GRCh37] Chr16:85541213..87929723 [NCBI36] Chr16:16q24.1-24.3	pathogenic
GRCh38/hg38 16q24.2(chr16:87267492-87780225)x1	copy number loss	See cases [RCV000143657]	Chr16:87267492..87780225 [GRCh38] Chr16:87301098..87813831 [GRCh37] Chr16:85858599..86371332 [NCBI36] Chr16:16q24.2	likely pathogenic\|uncertain significance
GRCh37/hg19 16q23.1-24.3(chr16:74872514-90274440)x3	copy number gain	See cases [RCV000240108]	Chr16:74872514..90274440 [GRCh37] Chr16:16q23.1-24.3	pathogenic
t(5;16)(p15.31;q23.1)	translocation	not provided [RCV000203391]	Chr5:1..8180513 [GRCh37] Chr16:76935310..90354753 [GRCh37] Chr5:5p15.33-15.31 Chr16:16q23.1-24.3	likely pathogenic
Single allele	deletion	16q24.3 microdeletion syndrome [RCV000258230]	Chr16:87183661..89520803 [GRCh37] Chr16:16q24.2-24.3	pathogenic
Single allele	deletion	16q24.3 microdeletion syndrome [RCV000258380]	Chr16:87340135..89335428 [GRCh37] Chr16:16q24.2-24.3	pathogenic
GRCh37/hg19 16q11.2-24.3(chr16:46615804-90142285)x1	copy number loss	Breast ductal adenocarcinoma [RCV000207138]	Chr16:46615804..90142285 [GRCh37] Chr16:16q11.2-24.3	uncertain significance
GRCh37/hg19 16q22.2-24.3(chr16:72107834-90142285)x1	copy number loss	Breast ductal adenocarcinoma [RCV000207182]	Chr16:72107834..90142285 [GRCh37] Chr16:16q22.2-24.3	uncertain significance
Single allele	complex	Breast ductal adenocarcinoma [RCV000207314]	Chr16:56368689..90141355 [GRCh37] Chr16:16q12.2-24.3	uncertain significance
GRCh37/hg19 16q11.2-24.3(chr16:46464488-90155062)x3	copy number gain	See cases [RCV000446110]	Chr16:46464488..90155062 [GRCh37] Chr16:16q11.2-24.3	pathogenic
GRCh37/hg19 16q24.2(chr16:87409427-87446304)x1	copy number loss	See cases [RCV000446674]	Chr16:87409427..87446304 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3	copy number gain	See cases [RCV000446684]	Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16q24.1-24.2(chr16:85491404-87883528)x1	copy number loss	See cases [RCV000510624]	Chr16:85491404..87883528 [GRCh37] Chr16:16q24.1-24.2	pathogenic
GRCh37/hg19 16q24.2-24.3(chr16:87219866-89561087)x1	copy number loss	not provided [RCV000509325]	Chr16:87219866..89561087 [GRCh37] Chr16:16q24.2-24.3	not provided
GRCh37/hg19 16q24.2(chr16:87428533-87486111)x1	copy number loss	See cases [RCV000511653]	Chr16:87428533..87486111 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q24.2(chr16:87333237-87457042)x1	copy number loss	See cases [RCV000511682]	Chr16:87333237..87457042 [GRCh37] Chr16:16q24.2	likely pathogenic
GRCh37/hg19 16p13.2-q24.3(chr16:9273328-89548493)x3	copy number gain	See cases [RCV000511622]	Chr16:9273328..89548493 [GRCh37] Chr16:16p13.2-q24.3	uncertain significance
GRCh37/hg19 16q24.1-24.3(chr16:84937273-89836905)x4	copy number gain	See cases [RCV000511606]	Chr16:84937273..89836905 [GRCh37] Chr16:16q24.1-24.3	likely pathogenic
NM_015144.3(ZCCHC14):c.2279C>T (p.Thr760Met)	single nucleotide variant	not specified [RCV004294866]	Chr16:87412442 [GRCh38] Chr16:87446048 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1235G>A (p.Arg412Gln)	single nucleotide variant	not specified [RCV004301385]	Chr16:87417608 [GRCh38] Chr16:87451214 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1210A>G (p.Ser404Gly)	single nucleotide variant	not specified [RCV004318097]	Chr16:87417633 [GRCh38] Chr16:87451239 [GRCh37] Chr16:16q24.2	likely benign
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3	copy number gain	See cases [RCV000512138]	Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
NM_015144.3(ZCCHC14):c.1043C>A (p.Pro348Gln)	single nucleotide variant	not specified [RCV004298585]	Chr16:87419785 [GRCh38] Chr16:87453391 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q11.2-24.3(chr16:46497599-90354753)x1	copy number loss	Poly (ADP-Ribose) polymerase inhibitor response [RCV000626429]	Chr16:46497599..90354753 [GRCh37] Chr16:16q11.2-24.3	drug response
GRCh37/hg19 16q13-24.3(chr16:57051473-89797669)x3	copy number gain	See cases [RCV000512511]	Chr16:57051473..89797669 [GRCh37] Chr16:16q13-24.3	pathogenic
GRCh37/hg19 16q24.1-24.3(chr16:85838574-90155062)x3	copy number gain	See cases [RCV000512440]	Chr16:85838574..90155062 [GRCh37] Chr16:16q24.1-24.3	pathogenic
GRCh37/hg19 16q23.3-24.3(chr16:83001540-90155062)x3	copy number gain	See cases [RCV000512468]	Chr16:83001540..90155062 [GRCh37] Chr16:16q23.3-24.3	likely pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)	copy number gain	See cases [RCV000511296]	Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16q11.2-24.3(chr16:46455960-90354753)x1	copy number loss	Poly (ADP-Ribose) polymerase inhibitor response [RCV000626435]	Chr16:46455960..90354753 [GRCh37] Chr16:16q11.2-24.3	drug response
Single allele	deletion	not provided [RCV000677910]	Chr16:86890893..89398630 [GRCh37] Chr16:16q24.1-24.3	pathogenic
GRCh37/hg19 16q24.2(chr16:87149360-87848903)x1	copy number loss	not provided [RCV000683854]	Chr16:87149360..87848903 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q24.2(chr16:87307128-87551687)x1	copy number loss	not provided [RCV000683855]	Chr16:87307128..87551687 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q23.2-24.3(chr16:79400436-90155062)x3	copy number gain	not provided [RCV000683845]	Chr16:79400436..90155062 [GRCh37] Chr16:16q23.2-24.3	pathogenic
GRCh37/hg19 16q22.2-24.3(chr16:72515938-90155062)x3	copy number gain	not provided [RCV000683831]	Chr16:72515938..90155062 [GRCh37] Chr16:16q22.2-24.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3	copy number gain	not provided [RCV000738917]	Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3	copy number gain	not provided [RCV000738918]	Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3	copy number gain	not provided [RCV000738915]	Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16q24.2(chr16:87153890-87518829)x1	copy number loss	not provided [RCV000751802]	Chr16:87153890..87518829 [GRCh37] Chr16:16q24.2	benign
NM_015144.3(ZCCHC14):c.3144C>T (p.Cys1048=)	single nucleotide variant	not provided [RCV000949392]	Chr16:87411577 [GRCh38] Chr16:87445183 [GRCh37] Chr16:16q24.2	benign
GRCh37/hg19 16q23.3-24.3(chr16:82761333-90055381)	copy number gain	not provided [RCV000767619]	Chr16:82761333..90055381 [GRCh37] Chr16:16q23.3-24.3	pathogenic
NM_015144.3(ZCCHC14):c.883C>A (p.Pro295Thr)	single nucleotide variant	not provided [RCV000965335]	Chr16:87420674 [GRCh38] Chr16:87454280 [GRCh37] Chr16:16q24.2	benign
GRCh37/hg19 16q24.2(chr16:87513448-87930837)x1	copy number loss	not provided [RCV000848541]	Chr16:87513448..87930837 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q24.2(chr16:87409427-87603006)x1	copy number loss	not provided [RCV001006837]	Chr16:87409427..87603006 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2576C>T (p.Thr859Met)	single nucleotide variant	not specified [RCV004321420]	Chr16:87412145 [GRCh38] Chr16:87445751 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2297T>A (p.Val766Asp)	single nucleotide variant	not specified [RCV004313528]	Chr16:87412424 [GRCh38] Chr16:87446030 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2655C>A (p.Gly885=)	single nucleotide variant	not provided [RCV000891992]	Chr16:87412066 [GRCh38] Chr16:87445672 [GRCh37] Chr16:16q24.2	benign
NM_015144.3(ZCCHC14):c.1166C>T (p.Pro389Leu)	single nucleotide variant	not provided [RCV000960968]	Chr16:87417677 [GRCh38] Chr16:87451283 [GRCh37] Chr16:16q24.2	benign
GRCh37/hg19 16q24.1-24.2(chr16:84872102-87678641)	copy number loss	Alveolar capillary dysplasia with pulmonary venous misalignment [RCV001004081]	Chr16:84872102..87678641 [GRCh37] Chr16:16q24.1-24.2	pathogenic
GRCh37/hg19 16q21-24.3(chr16:61524229-90155062)x3	copy number gain	not provided [RCV001249359]	Chr16:61524229..90155062 [GRCh37] Chr16:16q21-24.3	not provided
NM_015144.3(ZCCHC14):c.899C>T (p.Pro300Leu)	single nucleotide variant	not specified [RCV004686152]	Chr16:87420658 [GRCh38] Chr16:87454264 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1508C>T (p.Ser503Leu)	single nucleotide variant	not specified [RCV004686153]	Chr16:87414509 [GRCh38] Chr16:87448115 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2725C>T (p.Pro909Ser)	single nucleotide variant	not specified [RCV004686156]	Chr16:87411996 [GRCh38] Chr16:87445602 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.3022G>A (p.Ala1008Thr)	single nucleotide variant	not specified [RCV004686160]	Chr16:87411699 [GRCh38] Chr16:87445305 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.3101G>A (p.Gly1034Asp)	single nucleotide variant	not specified [RCV004686162]	Chr16:87411620 [GRCh38] Chr16:87445226 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q23.2-24.3(chr16:80386595-90163348)x3	copy number gain	not provided [RCV001795551]	Chr16:80386595..90163348 [GRCh37] Chr16:16q23.2-24.3	pathogenic
NC_000016.9:g.86243180_87703229del	deletion	Alveolar capillary dysplasia with pulmonary venous misalignment [RCV001199829]	Chr16:86243180..87703229 [GRCh37] Chr16:16q24.1-24.2	pathogenic
GRCh37/hg19 16q11.2-24.3(chr16:46503968-90155062)x3	copy number gain	not provided [RCV002221458]	Chr16:46503968..90155062 [GRCh37] Chr16:16q11.2-24.3	pathogenic
NM_015144.3(ZCCHC14):c.2207C>G (p.Ala736Gly)	single nucleotide variant	not specified [RCV004291814]	Chr16:87412514 [GRCh38] Chr16:87446120 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q22.2-24.3(chr16:71641395-90161959)x3	copy number gain	Syndromic anorectal malformation [RCV002286607]	Chr16:71641395..90161959 [GRCh37] Chr16:16q22.2-24.3	likely pathogenic
NM_015144.3(ZCCHC14):c.2312G>T (p.Arg771Leu)	single nucleotide variant	not specified [RCV004328454]	Chr16:87412409 [GRCh38] Chr16:87446015 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2314C>T (p.Pro772Ser)	single nucleotide variant	not specified [RCV004328455]	Chr16:87412407 [GRCh38] Chr16:87446013 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1133C>T (p.Ser378Leu)	single nucleotide variant	not specified [RCV004218541]	Chr16:87417710 [GRCh38] Chr16:87451316 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1805T>A (p.Phe602Tyr)	single nucleotide variant	not specified [RCV004110441]	Chr16:87412916 [GRCh38] Chr16:87446522 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2917G>A (p.Val973Ile)	single nucleotide variant	not specified [RCV004143425]	Chr16:87411804 [GRCh38] Chr16:87445410 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2795G>A (p.Gly932Asp)	single nucleotide variant	not specified [RCV004139875]	Chr16:87411926 [GRCh38] Chr16:87445532 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2443A>G (p.Thr815Ala)	single nucleotide variant	not specified [RCV004161748]	Chr16:87412278 [GRCh38] Chr16:87445884 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1701G>T (p.Gln567His)	single nucleotide variant	not specified [RCV004126678]	Chr16:87413098 [GRCh38] Chr16:87446704 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2204A>G (p.His735Arg)	single nucleotide variant	not specified [RCV004224295]	Chr16:87412517 [GRCh38] Chr16:87446123 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.523G>T (p.Ala175Ser)	single nucleotide variant	not specified [RCV004121247]	Chr16:87491716 [GRCh38] Chr16:87525322 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2312G>A (p.Arg771His)	single nucleotide variant	not specified [RCV004220099]	Chr16:87412409 [GRCh38] Chr16:87446015 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2525A>G (p.Asn842Ser)	single nucleotide variant	not specified [RCV004218787]	Chr16:87412196 [GRCh38] Chr16:87445802 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1948G>A (p.Val650Met)	single nucleotide variant	not specified [RCV004193084]	Chr16:87412773 [GRCh38] Chr16:87446379 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.3017C>T (p.Thr1006Met)	single nucleotide variant	not specified [RCV004098763]	Chr16:87411704 [GRCh38] Chr16:87445310 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.698G>A (p.Ser233Asn)	single nucleotide variant	not specified [RCV004132524]	Chr16:87433198 [GRCh38] Chr16:87466804 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1075G>C (p.Gly359Arg)	single nucleotide variant	not specified [RCV004119395]	Chr16:87418872 [GRCh38] Chr16:87452478 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2308G>A (p.Ala770Thr)	single nucleotide variant	not specified [RCV004227387]	Chr16:87412413 [GRCh38] Chr16:87446019 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.3025G>A (p.Val1009Met)	single nucleotide variant	not specified [RCV004154237]	Chr16:87411696 [GRCh38] Chr16:87445302 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2575A>T (p.Thr859Ser)	single nucleotide variant	not specified [RCV004119532]	Chr16:87412146 [GRCh38] Chr16:87445752 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.625G>T (p.Ala209Ser)	single nucleotide variant	not specified [RCV004148585]	Chr16:87460077 [GRCh38] Chr16:87493683 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2504G>T (p.Gly835Val)	single nucleotide variant	not specified [RCV004120782]	Chr16:87412217 [GRCh38] Chr16:87445823 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2812G>T (p.Gly938Cys)	single nucleotide variant	not specified [RCV004145991]	Chr16:87411909 [GRCh38] Chr16:87445515 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1219T>C (p.Ser407Pro)	single nucleotide variant	not specified [RCV004230669]	Chr16:87417624 [GRCh38] Chr16:87451230 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.3085G>A (p.Val1029Met)	single nucleotide variant	not specified [RCV004145992]	Chr16:87411636 [GRCh38] Chr16:87445242 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2200G>A (p.Val734Met)	single nucleotide variant	not specified [RCV004227968]	Chr16:87412521 [GRCh38] Chr16:87446127 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.3074C>T (p.Thr1025Ile)	single nucleotide variant	not specified [RCV004144720]	Chr16:87411647 [GRCh38] Chr16:87445253 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1213G>A (p.Ala405Thr)	single nucleotide variant	not specified [RCV004109272]	Chr16:87417630 [GRCh38] Chr16:87451236 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1277G>C (p.Ser426Thr)	single nucleotide variant	not specified [RCV004175423]	Chr16:87417566 [GRCh38] Chr16:87451172 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.3080G>T (p.Gly1027Val)	single nucleotide variant	not specified [RCV004160898]	Chr16:87411641 [GRCh38] Chr16:87445247 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2528C>G (p.Thr843Ser)	single nucleotide variant	not specified [RCV004196519]	Chr16:87412193 [GRCh38] Chr16:87445799 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2350G>A (p.Ala784Thr)	single nucleotide variant	not specified [RCV004171959]	Chr16:87412371 [GRCh38] Chr16:87445977 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1801C>T (p.His601Tyr)	single nucleotide variant	not specified [RCV004167662]	Chr16:87412920 [GRCh38] Chr16:87446526 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2158T>A (p.Ser720Thr)	single nucleotide variant	not specified [RCV004141138]	Chr16:87412563 [GRCh38] Chr16:87446169 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2270C>T (p.Thr757Met)	single nucleotide variant	not specified [RCV004260249]	Chr16:87412451 [GRCh38] Chr16:87446057 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2687C>T (p.Ser896Leu)	single nucleotide variant	not specified [RCV004286912]	Chr16:87412034 [GRCh38] Chr16:87445640 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q24.1-24.2(chr16:86544176-88110267)x1	copy number loss	not provided [RCV003222894]	Chr16:86544176..88110267 [GRCh37] Chr16:16q24.1-24.2	pathogenic
NM_015144.3(ZCCHC14):c.619G>C (p.Glu207Gln)	single nucleotide variant	not specified [RCV004267813]	Chr16:87460083 [GRCh38] Chr16:87493689 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2618C>T (p.Ser873Phe)	single nucleotide variant	not specified [RCV004272082]	Chr16:87412103 [GRCh38] Chr16:87445709 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2989C>T (p.Pro997Ser)	single nucleotide variant	not specified [RCV004316349]	Chr16:87411732 [GRCh38] Chr16:87445338 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1877G>T (p.Gly626Val)	single nucleotide variant	not specified [RCV004309149]	Chr16:87412844 [GRCh38] Chr16:87446450 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2756C>T (p.Pro919Leu)	single nucleotide variant	not specified [RCV004335309]	Chr16:87411965 [GRCh38] Chr16:87445571 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1572C>T (p.Pro524=)	single nucleotide variant	not provided [RCV003419481]	Chr16:87414445 [GRCh38] Chr16:87448051 [GRCh37] Chr16:16q24.2	likely benign
NM_015144.3(ZCCHC14):c.645T>A (p.His215Gln)	single nucleotide variant	not specified [RCV004365307]	Chr16:87460057 [GRCh38] Chr16:87493663 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2213C>T (p.Thr738Met)	single nucleotide variant	not specified [RCV004339876]	Chr16:87412508 [GRCh38] Chr16:87446114 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2809A>G (p.Ser937Gly)	single nucleotide variant	not specified [RCV004357695]	Chr16:87411912 [GRCh38] Chr16:87445518 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q24.1-24.2(chr16:84555718-87910245)x1	copy number loss	not provided [RCV003483302]	Chr16:84555718..87910245 [GRCh37] Chr16:16q24.1-24.2	pathogenic
NM_015144.3(ZCCHC14):c.2910C>T (p.Ser970=)	single nucleotide variant	not provided [RCV003426884]	Chr16:87411811 [GRCh38] Chr16:87445417 [GRCh37] Chr16:16q24.2	likely benign
Single allele	deletion	KBG syndrome [RCV003388953]	Chr16:87169884..89487487 [GRCh38] Chr16:16q24.2-24.3	pathogenic
GRCh37/hg19 16q24.2(chr16:87213180-87474058)x1	copy number loss	not specified [RCV003987182]	Chr16:87213180..87474058 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q23.3-24.3(chr16:82865402-90163542)x3	copy number gain	not provided [RCV004577473]	Chr16:82865402..90163542 [GRCh37] Chr16:16q23.3-24.3	pathogenic
NM_015144.3(ZCCHC14):c.1493G>A (p.Arg498Gln)	single nucleotide variant	not specified [RCV004483408]	Chr16:87414524 [GRCh38] Chr16:87448130 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.532C>T (p.Pro178Ser)	single nucleotide variant	not specified [RCV004483409]	Chr16:87491707 [GRCh38] Chr16:87525313 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1670C>A (p.Ser557Tyr)	single nucleotide variant	not specified [RCV004483410]	Chr16:87413129 [GRCh38] Chr16:87446735 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1934G>A (p.Arg645His)	single nucleotide variant	not specified [RCV004483411]	Chr16:87412787 [GRCh38] Chr16:87446393 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1942A>T (p.Asn648Tyr)	single nucleotide variant	not specified [RCV004483412]	Chr16:87412779 [GRCh38] Chr16:87446385 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2083G>A (p.Ala695Thr)	single nucleotide variant	not specified [RCV004483413]	Chr16:87412638 [GRCh38] Chr16:87446244 [GRCh37] Chr16:16q24.2	likely benign
NM_015144.3(ZCCHC14):c.2105C>T (p.Ala702Val)	single nucleotide variant	not specified [RCV004483414]	Chr16:87412616 [GRCh38] Chr16:87446222 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2110G>A (p.Ala704Thr)	single nucleotide variant	not specified [RCV004483415]	Chr16:87412611 [GRCh38] Chr16:87446217 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.583A>G (p.Thr195Ala)	single nucleotide variant	not specified [RCV004483417]	Chr16:87460119 [GRCh38] Chr16:87493725 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.635C>G (p.Thr212Arg)	single nucleotide variant	not specified [RCV004483419]	Chr16:87460067 [GRCh38] Chr16:87493673 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2681C>A (p.Pro894His)	single nucleotide variant	not specified [RCV004483420]	Chr16:87412040 [GRCh38] Chr16:87445646 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2834A>G (p.Asn945Ser)	single nucleotide variant	not specified [RCV004483421]	Chr16:87411887 [GRCh38] Chr16:87445493 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2935G>A (p.Gly979Ser)	single nucleotide variant	not specified [RCV004483422]	Chr16:87411786 [GRCh38] Chr16:87445392 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2956G>C (p.Val986Leu)	single nucleotide variant	not specified [RCV004483423]	Chr16:87411765 [GRCh38] Chr16:87445371 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.684A>T (p.Lys228Asn)	single nucleotide variant	not specified [RCV004483424]	Chr16:87460018 [GRCh38] Chr16:87493624 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.3202C>T (p.Pro1068Ser)	single nucleotide variant	not specified [RCV004483425]	Chr16:87411519 [GRCh38] Chr16:87445125 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1180G>A (p.Ala394Thr)	single nucleotide variant	not specified [RCV004483426]	Chr16:87417663 [GRCh38] Chr16:87451269 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.586G>A (p.Glu196Lys)	single nucleotide variant	not specified [RCV004686154]	Chr16:87460116 [GRCh38] Chr16:87493722 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2938G>A (p.Gly980Ser)	single nucleotide variant	not specified [RCV004686151]	Chr16:87411783 [GRCh38] Chr16:87445389 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2645G>A (p.Ser882Asn)	single nucleotide variant	not specified [RCV004686158]	Chr16:87412076 [GRCh38] Chr16:87445682 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1691T>C (p.Met564Thr)	single nucleotide variant	not specified [RCV004686159]	Chr16:87413108 [GRCh38] Chr16:87446714 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1057C>G (p.Pro353Ala)	single nucleotide variant	not specified [RCV004686155]	Chr16:87418890 [GRCh38] Chr16:87452496 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2267G>A (p.Ser756Asn)	single nucleotide variant	not specified [RCV004686157]	Chr16:87412454 [GRCh38] Chr16:87446060 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.761C>G (p.Ser254Cys)	single nucleotide variant	not specified [RCV004885167]	Chr16:87433135 [GRCh38] Chr16:87466741 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1498C>G (p.Leu500Val)	single nucleotide variant	not specified [RCV004885162]	Chr16:87414519 [GRCh38] Chr16:87448125 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2911G>A (p.Gly971Ser)	single nucleotide variant	not specified [RCV004885163]	Chr16:87411810 [GRCh38] Chr16:87445416 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1667A>G (p.Tyr556Cys)	single nucleotide variant	not specified [RCV004885170]	Chr16:87413132 [GRCh38] Chr16:87446738 [GRCh37] Chr16:16q24.2	likely benign
NM_015144.3(ZCCHC14):c.2777C>T (p.Thr926Met)	single nucleotide variant	not specified [RCV004885164]	Chr16:87411944 [GRCh38] Chr16:87445550 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1907G>C (p.Ser636Thr)	single nucleotide variant	not specified [RCV004885165]	Chr16:87412814 [GRCh38] Chr16:87446420 [GRCh37] Chr16:16q24.2	likely benign
NM_015144.3(ZCCHC14):c.688A>G (p.Ser230Gly)	single nucleotide variant	not specified [RCV004885169]	Chr16:87460014 [GRCh38] Chr16:87493620 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.1658C>A (p.Ser553Tyr)	single nucleotide variant	not specified [RCV004885171]	Chr16:87413141 [GRCh38] Chr16:87446747 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2866G>A (p.Val956Met)	single nucleotide variant	not specified [RCV004885172]	Chr16:87411855 [GRCh38] Chr16:87445461 [GRCh37] Chr16:16q24.2	likely benign
NM_015144.3(ZCCHC14):c.1123A>G (p.Ile375Val)	single nucleotide variant	not specified [RCV004885173]	Chr16:87417720 [GRCh38] Chr16:87451326 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.529G>A (p.Gly177Arg)	single nucleotide variant	not specified [RCV004885166]	Chr16:87491710 [GRCh38] Chr16:87525316 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.3025G>C (p.Val1009Leu)	single nucleotide variant	not specified [RCV004885174]	Chr16:87411696 [GRCh38] Chr16:87445302 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2092G>A (p.Asp698Asn)	single nucleotide variant	not specified [RCV004885168]	Chr16:87412629 [GRCh38] Chr16:87446235 [GRCh37] Chr16:16q24.2	uncertain significance
GRCh37/hg19 16q24.2(chr16:87502161-87913238)x1	copy number loss	not provided [RCV004819887]	Chr16:87502161..87913238 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2513G>A (p.Cys838Tyr)	single nucleotide variant	not specified [RCV004893160]	Chr16:87412208 [GRCh38] Chr16:87445814 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2095G>A (p.Val699Met)	single nucleotide variant	not specified [RCV004893156]	Chr16:87412626 [GRCh38] Chr16:87446232 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2428C>T (p.Arg810Trp)	single nucleotide variant	not specified [RCV004893157]	Chr16:87412293 [GRCh38] Chr16:87445899 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2738C>T (p.Pro913Leu)	single nucleotide variant	not specified [RCV004893158]	Chr16:87411983 [GRCh38] Chr16:87445589 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2054G>C (p.Ser685Thr)	single nucleotide variant	not specified [RCV004893161]	Chr16:87412667 [GRCh38] Chr16:87446273 [GRCh37] Chr16:16q24.2	uncertain significance
NM_015144.3(ZCCHC14):c.2077G>C (p.Gly693Arg)	single nucleotide variant	not specified [RCV004893159]	Chr16:87412644 [GRCh38] Chr16:87446250 [GRCh37] Chr16:16q24.2	uncertain significance

Confirmed Target Of

miRNA Gene	Mature miRNA	Method Name	Result Type	Data Type	Support Type	PMID
MIR142	hsa-miR-142-3p	Tarbase	external_info	Microarray	POSITIVE

Predicted Target Of

	Summary Value
Count of predictions:	2912
Count of miRNA genes:	977
Interacting mature miRNAs:	1173
Transcripts:	ENST00000268616, ENST00000561928, ENST00000565193, ENST00000568020
Prediction methods:	Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597432668	GWAS1528742_H	protein measurement QTL GWAS1528742 (human)		3e-11	protein measurement		16	87411757	87411758	Human
597335449	GWAS1431523_H	smoking initiation QTL GWAS1431523 (human)		3e-18	smoking initiation		16	87410647	87410648	Human
597234641	GWAS1330715_H	anxiety measurement QTL GWAS1330715 (human)		3e-14	anxiety measurement		16	87411088	87411089	Human
597245776	GWAS1341850_H	coffee consumption measurement, neuroticism measurement QTL GWAS1341850 (human)		4e-10	coffee consumption measurement, neuroticism measurement		16	87410128	87410129	Human
597052380	GWAS1148454_H	smoking status measurement QTL GWAS1148454 (human)		6e-08	smoking status measurement		16	87410128	87410129	Human
597108829	GWAS1204903_H	self reported educational attainment QTL GWAS1204903 (human)		1e-12	self reported educational attainment		16	87410128	87410129	Human
597186386	GWAS1282460_H	peak expiratory flow QTL GWAS1282460 (human)		2e-08	peak expiratory flow	maximum mid-expiratory flow (MMEF) (CMO:0000253)	16	87412447	87412448	Human
597174100	GWAS1270174_H	protein measurement QTL GWAS1270174 (human)		1e-17	protein measurement		16	87407289	87407290	Human
596964056	GWAS1083575_H	major depressive disorder QTL GWAS1083575 (human)		0.000005	major depressive disorder		16	87428363	87428364	Human
597052568	GWAS1148642_H	anxiety QTL GWAS1148642 (human)		5e-09	anxiety		16	87477955	87477956	Human
597257035	GWAS1353109_H	schizophrenia QTL GWAS1353109 (human)		0.0000003	schizophrenia		16	87418978	87418979	Human
597073284	GWAS1169358_H	feeling nervous measurement QTL GWAS1169358 (human)		3e-08	feeling nervous measurement		16	87458843	87458844	Human
597212877	GWAS1308951_H	self reported educational attainment QTL GWAS1308951 (human)		9e-11	self reported educational attainment		16	87410128	87410129	Human
406997208	GWAS646184_H	intelligence QTL GWAS646184 (human)		0.000007	intelligence		16	87410128	87410129	Human
597077302	GWAS1173376_H	schizophrenia, major depressive disorder QTL GWAS1173376 (human)		5e-09	schizophrenia, major depressive disorder		16	87456092	87456093	Human
597109878	GWAS1205952_H	mathematical ability QTL GWAS1205952 (human)		4e-10	mathematical ability		16	87412233	87412234	Human
596973748	GWAS1093267_H	schizophrenia, major depressive disorder QTL GWAS1093267 (human)		5e-09	schizophrenia, major depressive disorder		16	87456092	87456093	Human
407043360	GWAS692336_H	unipolar depression QTL GWAS692336 (human)		0.000005	unipolar depression		16	87428363	87428364	Human
597203643	GWAS1299717_H	neuroticism measurement QTL GWAS1299717 (human)		9e-09	neuroticism measurement		16	87411088	87411089	Human
597094578	GWAS1190652_H	schizophrenia QTL GWAS1190652 (human)		0.000002	schizophrenia		16	87456285	87456286	Human
597345598	GWAS1441672_H	smoking initiation QTL GWAS1441672 (human)		3e-10	smoking initiation		16	87466604	87466605	Human
597229823	GWAS1325897_H	smoking status measurement QTL GWAS1325897 (human)		9e-12	smoking status measurement		16	87410128	87410129	Human
597203262	GWAS1299336_H	wellbeing measurement QTL GWAS1299336 (human)		4e-08	wellness/fitness trait (VT:1000152)		16	87412447	87412448	Human
407142122	GWAS791098_H	unipolar depression, schizophrenia QTL GWAS791098 (human)		5e-09	unipolar depression, schizophrenia		16	87456092	87456093	Human
597052327	GWAS1148401_H	neuroticism measurement QTL GWAS1148401 (human)		1e-09	neuroticism measurement		16	87412233	87412234	Human
597322537	GWAS1418611_H	smoking initiation QTL GWAS1418611 (human)		1e-16	smoking initiation		16	87410128	87410129	Human
597231085	GWAS1327159_H	smoking status measurement QTL GWAS1327159 (human)		7e-09	smoking status measurement		16	87410128	87410129	Human
597116591	GWAS1212665_H	cognitive function measurement QTL GWAS1212665 (human)		1e-10	cognitive behavior trait (VT:0010450)		16	87410128	87410129	Human
597047023	GWAS1143097_H	neuroticism measurement QTL GWAS1143097 (human)		6e-09	neuroticism measurement		16	87412447	87412448	Human
597029353	GWAS1125427_H	self reported educational attainment QTL GWAS1125427 (human)		4e-09	self reported educational attainment		16	87410128	87410129	Human
597343207	GWAS1439281_H	neuroticism measurement, cognitive function measurement QTL GWAS1439281 (human)		9e-14	cognitive behavior trait (VT:0010450)		16	87407289	87407290	Human
597031915	GWAS1127989_H	mood instability measurement QTL GWAS1127989 (human)		3e-12	mood instability measurement		16	87407289	87407290	Human
597074153	GWAS1170227_H	neuroticism measurement QTL GWAS1170227 (human)		0.000001	neuroticism measurement		16	87411757	87411758	Human

SHGC-79020

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	87,467,565 - 87,467,784	UniSTS	GRCh37
Build 36	16	86,025,066 - 86,025,285	RGD	NCBI36
Celera	16	71,764,361 - 71,764,580	RGD
Cytogenetic Map	16	q24.2	UniSTS
HuRef	16	73,209,967 - 73,210,186	UniSTS
TNG Radiation Hybrid Map	16	39708.0	UniSTS

SHGC-61175

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	87,439,985 - 87,440,119	UniSTS	GRCh37
Build 36	16	85,997,486 - 85,997,620	RGD	NCBI36
Celera	16	71,736,752 - 71,736,886	RGD
Cytogenetic Map	16	q24.2	UniSTS
HuRef	16	73,182,399 - 73,182,533	UniSTS
GeneMap99-GB4 RH Map	16	481.86	UniSTS

RH48496

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	87,443,211 - 87,443,362	UniSTS	GRCh37
Build 36	16	86,000,712 - 86,000,863	RGD	NCBI36
Celera	16	71,739,978 - 71,740,129	RGD
Cytogenetic Map	16	q24.2	UniSTS
HuRef	16	73,185,625 - 73,185,776	UniSTS
GeneMap99-GB4 RH Map	16	482.07	UniSTS

STS-Z40721

Human Assembly	Chr	Position (strand)	Source
Cytogenetic Map	16	q24.2	UniSTS
Cytogenetic Map	X	q28	UniSTS
GeneMap99-GB4 RH Map	6	457.04	UniSTS
NCBI RH Map	6	1388.6	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system
1204	2432	2788	2245	4942	1723	2345	4	622	1935	464	2268	7268	6441	52	3708	847	1731	1612	171


RefSeq Transcripts	NM_015144	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_005255858	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011522964	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017023082	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054379872	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054379873	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_008489065	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_243401	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB011151	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AB030243	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC010531	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC092720	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC105429	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK289682	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL117532	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC028304	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC038944	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC101478	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471114	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CN352228	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068262	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DB038312	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000268616 ⟹ ENSP00000268616

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	87,406,246 - 87,491,854 (-)	Ensembl

Ensembl Acc Id:

ENST00000561928 ⟹ ENSP00000456499

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	87,411,412 - 87,433,134 (-)	Ensembl

Ensembl Acc Id:

ENST00000565193

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	87,415,312 - 87,417,926 (-)	Ensembl

Ensembl Acc Id:

ENST00000568020 ⟹ ENSP00000455431

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	87,406,257 - 87,491,859 (-)	Ensembl

Ensembl Acc Id:

ENST00000671377 ⟹ ENSP00000499622

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	87,406,248 - 87,493,024 (-)	Ensembl

RefSeq Acc Id:

NM_015144 ⟹ NP_055959

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	87,406,248 - 87,493,024 (-)	NCBI
GRCh37	16	87,439,852 - 87,525,870 (-)	NCBI
Build 36	16	85,997,353 - 86,082,961 (-)	NCBI Archive
Celera	16	71,736,619 - 71,822,230 (-)	RGD
HuRef	16	73,182,266 - 73,267,848 (-)	RGD
CHM1_1	16	88,851,639 - 88,937,191 (-)	NCBI
T2T-CHM13v2.0	16	93,477,131 - 93,563,941 (-)	NCBI

Sequence:

show sequence

ACTTCTGCTGATCCCGGCCGCCCGTCAGCCGCGAGCGCGACGATCCCTCCGCTCCTCGGCCGGCGCCTCCTCCGCCGTCGCCGTCGCCGTCGCCGTCGCCGTCGCCGCCGCCGCCGCGCTCGGGCCCG
GATCCGTCCGCCGCGCGGGAGCAGCAAGGCCGGCAAGTCCCGGCCGGATCCCTCCGCGCCTCCCGCCGCGCGTCCCTCCCCCTCCAGCGTCCGTTTCGCGGCCGCGGCCCCCAGCGCTCCCCAGGCGG
CGACGCCGCGCCCGCGGCCCGGGGTAACGGCCGGCCTGGGCGGAGGCGCGGGCGGCGGCGACGGCATGGCCGGGGCGGCTCCGTCGGGGGGCGGCCCGCAGTGACAGACCCTGCGGCGCGGGGGGAGA
TGGGGGCGGCCGCCTCCCGGGCGACGACGACGACGACGACGAGGAGCAGCCGCCGCCGCCGCCGCGCACCGGCCGCCGCTGGGCACGGGCGCGGGGAAGGCGCCTCCCCGTGAGCGGGGGGCCCGAGG
CCGCTCGCCGCCCCCGGCCGCCCCGGCCGCCCCGGGCCCCCCCGGCGCCCCGCGCGCGCCCGCCCGCCGGCCCCTGACGGGAGCCTTGCCCGGCCCCGGTCCCCGCCCCCGCCCCGGCGCCCGCCCGG
CCCGCGGCGCCCGCGCGCCCTCGCCCGGACCCGGCCCCGGCCCGCGCGTCCCCGGTCCCGGCGCGCCCCGGCCGCGGCCCCCGGCGCCCCCCGGCCGCCCCCGCGCGGTCCCCGGCCCCGGGTCGCGG
CGCGGCGCGGGCGGCAGCATGGTGGAGAAGCGCTGCCCGCTGCAGAGGGACGGCGTGTACCGCTGGTTCTCGGAGCTGCCGTCGCCGCAGCGCGTGGAGTTCCTGTGCGGCCTGCTGGACCTGTGCAT
CCCGCTCGAGCTTCGCTTCCTCGGCTCGTGCCTGGAGGACCTGGCCCGCAAGGACTACCACTCGCTGCGCGACTCGGAGATCAAGGCCAACAACCCGGCCGACCTGGGCAGCCTCACCAACCTGACGG
ACGAGGTGGTGCGCAGCAAGCTGCTGGTGTCGCTGGCGCTGCTGGGCTCGGAGCAGCGCGAGGCGGCGGGCGTGCTCTACCGCACGCTCACGCACATCGACTCCATCATCCACAACTACGGGCTGCAG
CTTAACGAGGGCCGCACGGGCGATGAGTTCCTGCTGCTGTTCACCATGGCCTCCAACCACCCGGCCTTCAGCTTCCACCAGAAGCAGGTGCTGCGCCAGGAGCTCACGCAGATCCAGAGCAGCCTGAA
CGGCGGCGGGGGCCACGGCGGCAAGGGCGCGCCCGGGCCGGGCGGCGCGCTGCCCACTTGCCCAGCCTGCCACAAGATCACTCCAAGAACTGAGGCCCCTGTCAGCAGTGTCAGTAATAGTTTGGAGA
ATGCCCTGCACACATCAGCACATTCCACGGAGGAGTCGCTGCCCAAGAGGCCCTTAGGAAAACACAGCAAAGTGAGTGTTGAAAAGATAGACCTGAAGGGATTATCACACACAAAAAATGACAGAAAT
GTTGAATGTTCCTTTGAGGTCTTGTGGTCTGATTCTTCAATAACATCAGTAACCAAATCTTCCTCTGAAGTGACGGAATTTATTTCAAAGCTATGTCAGCTCTATCCTGAAGAGAACTTGGAGAAACT
CATTCCTTGCTTAGCTGGTCCGGACGCATTTTATGTGGAGCGAAACCACGTGGATCTGGACTCAGGCCTGAGGTACCTGGCCTCATTACCTTCTCACGTGTTGAAAAATGACCATGTCAGGAGGTTTC
TCAGCACTTCCTCTCCCCCACAGCAGCTTCAGAGTCCAAGTCCTGGCAATCCCTCCCTTTCTAAAGTAGGTACCGTGATGGGCGTGTCTGGAAGGCCTGTGTGTGGAGTGGCTGGTATCCCGTCCTCG
CAGAGCGGAGCCCAGCACCACGGGCAGCACCCGGCCGGCTCCGCCGCCCCCTTGCCTCACTGCTCCCATGCGGGCAGCGCGGGCTCAGCCCTGGCCTACCGGACCCAGATGGACACATCACCTGCCAT
CCTCATGCCTTCCAGTCTGCAGACCCCTCAGACCCAGGAGCAGAATGGGATTCTAGACTGGCTTAGGAAACTGCGTTTGCACAAGTATTACCCCGTCTTTAAGCAGCTCTCCATGGAGAAGTTTTTGA
GCCTTACTGAAGAAGATCTGAATAAATTTGAGTCTCTTACCATGGGGGCAAAGAAGAAGCTCAAGACCCAGCTGGAGCTGGAAAAGGAGAAGTCAGAGAGACGGTGCCTGAACCCCTCGGCCCCGCCG
CTGGTCACCAGCAGTGGTGTGGCTCGAGTGCCCCCCACCAGCCACGTCGGGCCCGTGCAGTCGGGGCGGGGCAGCCATGCAGCAGAGCTGCGGGTGGAAGTGGAGCAGCCCCATCACCAGCTGCCCCG
GGAAGGCAGTTCCTCGGAGTACTCCAGCTCCTCCTCCAGCCCCATGGGGGTACAGGCCCGGGAAGAGAGCTCCGACAGCGCTGAGGAGAATGACAGACGTGTGGAGATTCACTTGGAGAGCTCTGACA
AGGAGAAGCCGGTGATGCTGCTGAATCACTTCACTTCCAGTTCCGCCAGACCCACGGCCCAGGTTCTCCCTGTGCAGAATGAGGCCAGCTCCAATCCATCAGGCCACCACCCCCTGCCCCCGCAGATG
CTGAGCGCAGCCTCACACATCACACCCATCCGCATGCTGAATTCCGTGCACAAGCCGGAAAGAGGGAGCGCGGACATGAAGCTCCTCTCGTCTTCTGTGCACTCACTTTTGTCTCTAGAAGAAAGGAA
TAAAGGATCTGGACCAAGAAGCAGCATGAAAGTGGACAAGAGCTTTGGCAGCGCCATGATGGACGTGCTGCCCGCGTCCGCACCCCACCAGCCTGTGCAGGTCCTCTCTGGGCTTTCGGAGAGCAGCT
CCATGTCACCCACAGTCTCCTTTGGTCCCCGGACCAAAGTCGTGCATGCATCCACGCTGGACAGGGTGCTGAAGACAGCACAGCAACCGGCCCTGGTCGTGGAGACCAGCACGGCCGCCACGGGGACG
CCCAGCACAGTCCTCCACGCCGCCCGTCCGCCCATCAAACTGCTGCTGTCGTCATCTGTTCCTGCTGATTCTGCCATTTCTGGGCAAACTTCCTGTCCTAATAATGTGCAAATAAGTGTGCCCCCTGC
AATAATAAACCCCCGGACTGCTCTGTACACAGCCAACACCAAAGTTGCCTTTTCTGCAATGAGCAGTATGCCAGTGGGCCCCCTGCAGGGTGGCTTCTGTGCAAACAGCAACACTGCCTCTCCCAGCA
GCCACCCCTCCACGTCCTTTGCCAACATGGCCACGTTGCCCAGCTGCCCAGCCCCCAGCTCCAGCCCGGCGCTGTCCTCCGTCCCTGAAAGCAGTTTCTATAGCAGCAGTGGCGGTGGCGGCTCCACA
GGAAACATTCCTGCCTCGAATCCGAACCACCACCACCACCACCACCATCAGCAGCCCCCGGCACCCCCGCAGCCCGCCCCACCCCCGCCAGGCTGCATTGTGTGCACGTCCTGTGGCTGCAGCGGCAG
CTGCGGCTCGAGTGGCCTGACTGTCAGCTACGCCAACTACTTCCAGCACCCGTTCTCCGGTCCGTCCGTGTTCACCTTCCCCTTCTTGCCCTTCAGTCCCATGTGCAGCAGCGGCTACGTCAGCGCCC
AGCAGTACGGCGGCGGCTCCACCTTCCCCGTCGTGCACGCCCCTTACAGCAGCAGCGGGACCCCAGACCCTGTCCTGAGTGGGCAGTCCACGTTTGCCGTGCCACCCATGCAGAACTTCATGGCAGGG
ACAGCAGGGGTGTACCAGACCCAAGGACTGGTGGGCAGTAGCAATGGTTCCAGTCACAAAAAGAGCGGGAACCTATCTTGTTACAACTGCGGGGCCACTGGTCACCGCGCCCAGGACTGCAAACAGCC
GTCCATGGACTTCAACCGGCCAGGTACTTTTAGGTTGAAATACGCCCCTCCAGCAGAAAGTCTGGACTCCACAGATTGATATTTTTCTCTGGCAACAGAACGTTATTAAGCCATGGAGACATAAGGAA
AATTAAATACAAAACTGAGAAGTCTAGTTGCTGTTGAGCTTAATCTTTTTAATCCAAAGGTGCTTTACTTTTCCTAGACTGGATAGAAAATCTAGCGTAGAAGTGCATCAAACTCGATTTATTGCCAA
AACCCTAGATTGGAGCTTGGTGTCAGAACTCGCCTAGTGGGCATCTCTGTGGCTGGTGAGATCGGCCACCTCCACTTTTGGTTGCAGTGCAGAGACGCCATGTCTCCCGAAGAGCATTGCCATCACTG
GCCCTCCTAGGCTCACACGTCAATTCCAGGGCAGCTACACGTGGTCTGAATCGAGAACCGAGCTTGGAGTTCTCCAAGTGGAGTTCCACCCGCCGGACTCCTGACACCCCTGGGCTAGGGAAAATGTC
GACTTTGTTTTGTTCTGTTCCTAAAGTGATTAGCACTAATCTCTGGGATTTTTAAGGATTGCACTACAGAAGAATGTACCCTGATGTAAATCTCTGCGGTTCTGGGAGCCAAACTCCTCTGAGAACAG
TCAGTGCAAGAGACTCCAATAATCCATATTGAAAGAGTCAGCACCAGCAGAGGCTACTCGACTTAGGACGCAACAGAGGTTTTAGTATTTCCTTCCCTCCTCCAAGCACTTGTAGCAGTTTCAGGTTT
TTAATTTTTTTCTGCAAATAAATCTAAACTACGTTATTAAATAGAAATAGTTTACTCGCAACAACTTAATTTCTAAGGGTCCAAGTCCCAGAGAATCCATAGTCGTCAAAGCTTTGAGAGTATCTTTC
TTCCCAGCCAGTCAGTGGCTTTGAGCCCTATCTTCCACTACAAATGACCTCTCGAGGGGGGACGGCGACAGCGCGGCTCTGTGAGTGGCTGTGAGGATGCTGCACGTCCTCAGCAGAGTTTGCAAGTT
GCTTTATCTCCCACGGGCTCCCCAAGAACCTCCAACCCCGAGGCTTATCGCTAGCGGATTCACACCTGAGACAGACATTTCAACAATGATACAGTCCTGTCATTTATCAGCAAAAGATTGGGAATTTT
CTCCTGTCAACTTCTTTTGTATTAGGCTGTGTATTGATAGTTAATTCCGTTAAAAATTACTTGGAAAACAGTGGGAAGTGGTAGGACTCTGGAAGAGGCCACACACCCGAGAGCTGCGAGATCTGTGC
AAGTCTGGTTTTGGTTAGGTAGTAATAAAAGTCCTCACTGTAGATCTCTAAATTTCAACCCACGGAAATGAAAGCCTTTTGTCTGAAATTTACGGACTTAAATCTTCAAGGTTAAAGGGAATTTTCTG
CTCAAATAATACTCTTATCGAAAATGCTAAAGTCTTCAATGTTAAAATACTGATTGGTAAAATCTTGCAGTTGGGATTTTGCAGTTGGATATTTATTTTAAAAAAAATTATAATATTCAGACTATTCT
TAAAATGGGACAATCAGCCTCATGAAAAATTGATGTAAATCAGAAGAATACCCTAGAATGAGGCCTTGTGATGTGAGCGTTCAATTTGAAGAGCAGTTCCTAACTTCATAGAAACTAAAGCAGAAAGT
TGTTACATTTTTTTTATGACAGGCTTTTAGTAGAATTTTTTAGTTTTATTTTAGTTGAATTTTATTTCTATGCAATGCAGAATTAACAGACCTCTTCTCCTCATGGTACACAGTATTACAGTGTTGAA
GTAATGGTGATGCTTATTACAACAGCTATTTAGGGGAATGTTACGTTGATCTCTTAAATTGTAAACACTACAAAATGTCAAAATAATGAGAACTGACACAACTTTGCCTTAAAGAGTACTAGACTGGA
CCTTCTCATATTACGTTTAAGGAAGACTTAGAGTGTTCATTGATGTTTACGATTTTAATATTTCTGAAGGCCATTACAGTGGCCTGGATATGTGCTGAAAGCCAAACTTTTAAATTTTTTGGTTTTTT
TAAGCAAAGAAATATTTTAAATAAATCCTATTTCAACACTGAAATTGTTGAAAACCGTCTCATAACAAAAGGAAAAAACATTGGAATTTTTGTTTTAGTGGTCAGTATAGGGGAATGAAAGCGTCTGT
TGTTACCCACGTAACTATTTTGATAAGTATTAGAGGTTAACCTTAAATCCAGCAAAACATTAAAACAGAAACTTTTCAACTTGGAGCCTGCCATTCAGCGTTGAGGTAGATGAGTTCCGACACTGTCA
CGGCTGTGTTCCCAGCAGCGAAGGCCTCTGCGGAGCTGCCAGTCGTCTTGAACGTGCATGGGCGGCGTGTGACATCTCCAGGGAGGCCGTCCGAAGTCGAGAATCGTCAGCTGTAAGTAGGAGCTACA
CAGCGCAGAGAAAATGGAACCACCCATCCGTGAGGCCTCTTTCCGGAGGGAGCCGCACACTTGGACTTGAGAGTTTGCCAGCAGCGAGCTCGGATGCATCTCTCCAAAAGCCACCAAGGTCGGCGCGT
CTGAAGAGCGTTTTGCGGTCATCAGACTTCCTCATCTGAAAACACAGAACATACTGACCCTTTCAAGTACTTAGTCATTTTCCTGAAAGTGTGGTCTGTTTCAGAATGCTGTGGCAACCAGGTAGGTG
TGGCACTGGCCATGTGCCACGTCTTTGCCCTTTGTAGTCTGTCAGATATTAAAGTTTCTAACCCTGTTTTTTTAATCTCCAAGAATGGGGAAAGTGGAATGTAGAGATGGAAGCAGAACGTGATGTTT
GGATACAACAGCTATTTAATCCTTTTTTATTTTTTAAGCAAAACACTCAGTTTTCTACCTTATTTTCTAATGTTGATTTCATGGTAATACTGACAGTTGGAAGTGTTTAACATAAAAACTCATTGCTA
AAGAGCACTGAGGAAATGGGAGCTAGCGCACTTGTAATAAAAATAAAGACAAAATATTTTCTTGAATGCATATATGTGATTGGGTATTTTAAAAACCAGTATCATCTGTCATCTCCAAAAGATTACAG
GAGTCAGCTTGTTAATACAGTAGTGTTAGTAGGTTCTGTATTTTTAATTCAGTACTTAGAATTCTAGGTCCTTTATTGCCCAAAGTCAGCACAGTTAGTTTATACCACAGACTCTGTCTTGGGGCACA
GTAGTGGGGCGGGGTAGTGACTTTGCCTAAACATCACCCAGCTGGAACAGAGGCTGAGCGGGGCTTTAGGCACTTGCCAGATGGGAACTGGGTTGCACCCTCCTTGCTCCCTGTCATTTTCTTGTCAC
TCTTCCTGCTTCCCAGTGTTTTATTTTATGCCTTGCTCGTTGTACATCATGATGACTGATGGTCTTCAAGGTTGTGAGGAAAGCCGTCTCCCTGCTTGACTCGACTGCTGTCCCAGAGGAGAGTCCTG
TGCGACCTGAGCGGGGGTGGCTGCCATTTCCAGCATGCAGGTGACTTCCAAAGAATGAGTCAGGTGGCACTGAAAGCCATGGGTTCTGAAGAGGCGAATTTGTTGAAAAGTCCCAAGGGTCTGAATGA
AAGCATCTTTAATCAACACTCAACACTCGCAATATTCTAGAAAACCATATACTGTGCTGGTTGAGGCCAAAGGTTAACATTGCTCCACTGTTCACCAAGGAAGGGGGCAGTGGCCATCCGCCGCGGCC
TCACGTGCGTTGTAACAAGCCCTCATCACATGTGTGAGTCTTACGTGCACAAAAAGAGAAGGCTTTGGTACTGAAACTGGACACCTTGTGTACTCGATACCTTCACAGCTTCTATTGGACATATTTTC
TTTTTAGGAATGAAGGAAAATTCTCCCATTTTTGAGCCATTCTTTTGTCAATTCTACAAAATTGCATGTAACTTTATAAATATTTTTAAAAGATATAGTTTTGTAAATATTTAATATTCCGCTAATTT
GATTTTGAATTGTAAATGTCAAGTATTCTGTTTTTGGGGTTTTTATGTTTTATTATACTTTGTTAAAAAGGACAAATTGTACATTTTTAGAATGTTTTTATGAGTAAATTTAATGTACTGAAAATAAA
AATTTTAAAAAAGGC

hide sequence

RefSeq Acc Id:

XM_005255858 ⟹ XP_005255915

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	87,411,415 - 87,493,024 (-)	NCBI
GRCh37	16	87,439,852 - 87,525,870 (-)	NCBI

Sequence:

show sequence

AGGCCAACAACCCGGCCGACCTGGGCAGCCTCACCAACCTGACGGACGAGGTGGTGCGCAGCAA
GCTGCTGGTGTCGCTGGCGCTGCTGGGCTCGGAGCAGCGCGAGGCGGCGGGCGTGCTCTACCGCACGCTCACGCACATCGACTCCATCATCCACAACTACGGGCTGCAGCTTAACGAGGGCCGCACGG
GCGATGAGTTCCTGCTGCTGTTCACCATGGCCTCCAACCACCCGGCCTTCAGCTTCCACCAGAAGCAGGTGCTGCGCCAGGAGCTCACGCAGATCCAGAGCAGCCTGAACGGCGGCGGGGGCCACGGC
GGCAAGGGCGCGCCCGGGCCGGGCGGCGCGCTGCCCACTTGCCCAGCCTGCCACAAGATCACTCCAAGAACTGAGGCCCCTGTCAGCAGTGTCAGTAATAGTTTGGAGAATGCCCTGCACACATCAGC
ACATTCCACGGAGGAGTCGCTGCCCAAGAGGCCCTTAGGAAAACACAGCAAAGTGAGTGTTGAAAAGATAGACCTGAAGGGATTATCACACACAAAAAATGACAGAAATGTTGAATGTTCCTTTGAGG
TCTTGTGGTCTGATTCTTCAATAACATCAGTAACCAAATCTTCCTCTGAAGTGACGGAATTTATTTCAAAGCTATGTCAGCTCTATCCTGAAGAGAACTTGGAGAAACTCATTCCTTGCTTAGCTGGT
CCGGACGCATTTTATGTGGAGCGAAACCACGTGGATCTGGACTCAGGCCTGAGGTACCTGGCCTCATTACCTTCTCACGTGTTGAAAAATGACCATGTCAGGAGGTTTCTCAGCACTTCCTCTCCCCC
ACAGCAGCTTCAGAGTCCAAGTCCTGGCAATCCCTCCCTTTCTAAAGTAGGTACCGTGATGGGCGTGTCTGGAAGGCCTGTGTGTGGAGTGGCTGGTATCCCGTCCTCGCAGAGCGGAGCCCAGCACC
ACGGGCAGCACCCGGCCGGCTCCGCCGCCCCCTTGCCTCACTGCTCCCATGCGGGCAGCGCGGGCTCAGCCCTGGCCTACCGGACCCAGATGGACACATCACCTGCCATCCTCATGCCTTCCAGTCTG
CAGACCCCTCAGACCCAGGAGCAGAATGGGATTCTAGACTGGCTTAGGAAACTGCGTTTGCACAAGTATTACCCCGTCTTTAAGCAGCTCTCCATGGAGAAGTTTTTGAGCCTTACTGAAGAAGATCT
GAATAAATTTGAGTCTCTTACCATGGGGGCAAAGAAGAAGCTCAAGACCCAGCTGGAGCTGGAAAAGGAGAAGTCAGAGAGACGGTGCCTGAACCCCTCGGCCCCGCCGCTGGTCACCAGCAGTGGTG
TGGCTCGAGTGCCCCCCACCAGCCACGTCGGGCCCGTGCAGTCGGGGCGGGGCAGCCATGCAGCAGAGCTGCGGGTGGAAGTGGAGCAGCCCCATCACCAGCTGCCCCGGGAAGGCAGTTCCTCGGAG
TACTCCAGCTCCTCCTCCAGCCCCATGGGGGTACAGGCCCGGGAAGAGAGCTCCGACAGCGCTGAGGAGAATGACAGACGTGTGGAGATTCACTTGGAGAGCTCTGACAAGGAGAAGCCGGTGATGCT
GCTGAATCACTTCACTTCCAGTTCCGCCAGACCCACGGCCCAGGTTCTCCCTGTGCAGAATGAGGCCAGCTCCAATCCATCAGGCCACCACCCCCTGCCCCCGCAGATGCTGAGCGCAGCCTCACACA
TCACACCCATCCGCATGCTGAATTCCGTGCACAAGCCGGAAAGAGGGAGCGCGGACATGAAGCTCCTCTCGTCTTCTGTGCACTCACTTTTGTCTCTAGAAGAAAGGAATAAAGGATCTGGACCAAGA
AGCAGCATGAAAGTGGACAAGAGCTTTGGCAGCGCCATGATGGACGTGCTGCCCGCGTCCGCACCCCACCAGCCTGTGCAGGTCCTCTCTGGGCTTTCGGAGAGCAGCTCCATGTCACCCACAGTCTC
CTTTGGTCCCCGGACCAAAGTCGTGCATGCATCCACGCTGGACAGGGTGCTGAAGACAGCACAGCAACCGGCCCTGGTCGTGGAGACCAGCACGGCCGCCACGGGGACGCCCAGCACAGTCCTCCACG
CCGCCCGTCCGCCCATCAAACTGCTGCTGTCGTCATCTGTTCCTGCTGATTCTGCCATTTCTGGGCAAACTTCCTGTCCTAATAATGTGCAAATAAGTGTGCCCCCTGCAATAATAAACCCCCGGACT
GCTCTGTACACAGCCAACACCAAAGTTGCCTTTTCTGCAATGAGCAGTATGCCAGTGGGCCCCCTGCAGGGTGGCTTCTGTGCAAACAGCAACACTGCCTCTCCCAGCAGCCACCCCTCCACGTCCTT
TGCCAACATGGCCACGTTGCCCAGCTGCCCAGCCCCCAGCTCCAGCCCGGCGCTGTCCTCCGTCCCTGAAAGCAGTTTCTATAGCAGCAGTGGCGGTGGCGGCTCCACAGGAAACATTCCTGCCTCGA
ATCCGAACCACCACCACCACCACCACCATCAGCAGCCCCCGGCACCCCCGCAGCCCGCCCCACCCCCGCCAGGCTGCATTGTGTGCACGTCCTGTGGCTGCAGCGGCAGCTGCGGCTCGAGTGGCCTG
ACTGTCAGCTACGCCAACTACTTCCAGCACCCGTTCTCCGGTCCGTCCGTGTTCACCTTCCCCTTCTTGCCCTTCAGTCCCATGTGCAGCAGCGGCTACGTCAGCGCCCAGCAGTACGGCGGCGGCTC
CACCTTCCCCGTCGTGCACGCCCCTTACAGCAGCAGCGGGACCCCAGACCCTGTCCTGAGTGGGCAGTCCACGTTTGCCGTGCCACCCATGCAGAACTTCATGGCAGGGACAGCAGGGGTGTACCAGA
CCCAAGGACTGGTGGGCAGTAGCAATGGTTCCAGTCACAAAAAGAGCGGGAACCTATCTTGTTACAACTGCGGGGCCACTGGTCACCGCGCCCAGGACTGCAAACAGCCGTCCATGGACTTCAACCGG
CCAGGTAAGCGCGCGCCATGGCCGCGCCCACCAGGCTCCCGCAGGACCAGTGCACACAAATGCTTGGTTTTTATGAAGAGTAAACTTCTTTCTTTGTAAAGCAAA

hide sequence

RefSeq Acc Id:

XM_017023082 ⟹ XP_016878571

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	87,411,415 - 87,465,448 (-)	NCBI

Sequence:

show sequence

ATCATGGTGAAGATTTACCTTGAAATATTCATGCAGCAGCATTATCATGTGGGAGCTGGTTAGAAATGCAAGATTCTCAGGCCCACCCCGGACCTCATGAATCAAACCTGCGTTTCAGCCAGATCCGG
AGGCATTTTGCACATTAAAGTTTGGAAGCAGAGGCCTCCTCTCTTTAAACTGTAACAGTAAGAAGGGTGATTGCATAAGAGCCAGAGGCGGGCTGCCCAAGTCCAGGTGCCCCTAGATGTGTGGCCAC
TGTGGAACCTCAGTCAGCTTTCCTGGAAGAGCCCCAGGGGCGGGTGTGCCCCGTGACTACCAGTAGCTTGCTTCAGAGTCATATTTCATTCCTGGGTTAGCGCTTTGTAGATGTGGTGGAACAATCTG
ATTGTCTGTTACATAATGTAGATTGCAGAAGTTTTTGTTTGAAATAGAAGTGCTTTCCGTTTGATTCTGAATTTCATTAAAATTTGGTGATATCATGATGTATTTTACAGATCCTTATTAACGGCCTG
CTTCATGCCAGGCCCAGTTCGAAGTGCAAAGGAACAGCAGTGAACAAAGCAAACCAGAAACACAGCTGCCTTGCTGAGCATCGAGAAGTCTTGCTAAGAAGGACGTTTGAGTATAGATGGGAAGGCAC
AGGGGCGCTTCCAGGCAGAGGGGACAGCCAGGGCGAAGGCCCCAGGCAGATGTGACTGCTGTGCCCAGGGCAGCAGTGCATGGAGTGAAGAGCTGGGGGAGGACTGGATGCCAGGTTGCAGGGGCCAG
GCAGAGGGTTTTTGTGGGTTGTGGGAAGAGGCTGGCTGTGGAGAGGAAGAGAGCAGCTTATCGTTGCCTTCCTAGCAGTAGCAGAAGGCAGCCTTTGGAGCCGGTCAGTCTTCCCTCTCGTGCACATC
AGGCCAGATGACGAGTCCTGCGGGTGAGCCTGAGTCAGAGAGCACTTGAGTGGAACATAGGTCACGTGGAGCAAACTAACTTCACCAAAAATAACCCCAAAACAGCATTTCTGGGAAACACAAGTGAA
GACAGCTTTCAATGTAAACAAAGGAACAAAGTTACGATAAAGGCTTGGTTGGAAAAAGTGAACATGTGGAAAACTAAGAAGAAATTCCTTGGGAAAATATACGGAGGAAAACAGATCACTCCAAGAAC
TGAGGCCCCTGTCAGCAGTGTCAGTAATAGTTTGGAGAATGCCCTGCACACATCAGCACATTCCACGGAGGAGTCGCTGCCCAAGAGGCCCTTAGGAAAACACAGCAAAGTGAGTGTTGAAAAGATAG
ACCTGAAGGGATTATCACACACAAAAAATGACAGAAATGTTGAATGTTCCTTTGAGGTCTTGTGGTCTGATTCTTCAATAACATCAGTAACCAAATCTTCCTCTGAAGTGACGGAATTTATTTCAAAG
CTATGTCAGCTCTATCCTGAAGAGAACTTGGAGAAACTCATTCCTTGCTTAGCTGGTCCGGACGCATTTTATGTGGAGCGAAACCACGTGGATCTGGACTCAGGCCTGAGGTACCTGGCCTCATTACC
TTCTCACGTGTTGAAAAATGACCATGTCAGGAGGTTTCTCAGCACTTCCTCTCCCCCACAGCAGCTTCAGAGTCCAAGTCCTGGCAATCCCTCCCTTTCTAAAGTAGGTACCGTGATGGGCGTGTCTG
GAAGGCCTGTGTGTGGAGTGGCTGGTATCCCGTCCTCGCAGAGCGGAGCCCAGCACCACGGGCAGCACCCGGCCGGCTCCGCCGCCCCCTTGCCTCACTGCTCCCATGCGGGCAGCGCGGGCTCAGCC
CTGGCCTACCGGACCCAGATGGACACATCACCTGCCATCCTCATGCCTTCCAGTCTGCAGACCCCTCAGACCCAGGAGCAGAATGGGATTCTAGACTGGCTTAGGAAACTGCGTTTGCACAAGTATTA
CCCCGTCTTTAAGCAGCTCTCCATGGAGAAGTTTTTGAGCCTTACTGAAGAAGATCTGAATAAATTTGAGTCTCTTACCATGGGGGCAAAGAAGAAGCTCAAGACCCAGCTGGAGCTGGAAAAGGAGA
AGTCAGAGAGACGGTGCCTGAACCCCTCGGCCCCGCCGCTGGTCACCAGCAGTGGTGTGGCTCGAGTGCCCCCCACCAGCCACGTCGGGCCCGTGCAGTCGGGGCGGGGCAGCCATGCAGCAGAGCTG
CGGGTGGAAGTGGAGCAGCCCCATCACCAGCTGCCCCGGGAAGGCAGTTCCTCGGAGTACTCCAGCTCCTCCTCCAGCCCCATGGGGGTACAGGCCCGGGAAGAGAGCTCCGACAGCGCTGAGGAGAA
TGACAGACGTGTGGAGATTCACTTGGAGAGCTCTGACAAGGAGAAGCCGGTGATGCTGCTGAATCACTTCACTTCCAGTTCCGCCAGACCCACGGCCCAGGTTCTCCCTGTGCAGAATGAGGCCAGCT
CCAATCCATCAGGCCACCACCCCCTGCCCCCGCAGATGCTGAGCGCAGCCTCACACATCACACCCATCCGCATGCTGAATTCCGTGCACAAGCCGGAAAGAGGGAGCGCGGACATGAAGCTCCTCTCG
TCTTCTGTGCACTCACTTTTGTCTCTAGAAGAAAGGAATAAAGGATCTGGACCAAGAAGCAGCATGAAAGTGGACAAGAGCTTTGGCAGCGCCATGATGGACGTGCTGCCCGCGTCCGCACCCCACCA
GCCTGTGCAGGTCCTCTCTGGGCTTTCGGAGAGCAGCTCCATGTCACCCACAGTCTCCTTTGGTCCCCGGACCAAAGTCGTGCATGCATCCACGCTGGACAGGGTGCTGAAGACAGCACAGCAACCGG
CCCTGGTCGTGGAGACCAGCACGGCCGCCACGGGGACGCCCAGCACAGTCCTCCACGCCGCCCGTCCGCCCATCAAACTGCTGCTGTCGTCATCTGTTCCTGCTGATTCTGCCATTTCTGGGCAAACT
TCCTGTCCTAATAATGTGCAAATAAGTGTGCCCCCTGCAATAATAAACCCCCGGACTGCTCTGTACACAGCCAACACCAAAGTTGCCTTTTCTGCAATGAGCAGTATGCCAGTGGGCCCCCTGCAGGG
TGGCTTCTGTGCAAACAGCAACACTGCCTCTCCCAGCAGCCACCCCTCCACGTCCTTTGCCAACATGGCCACGTTGCCCAGCTGCCCAGCCCCCAGCTCCAGCCCGGCGCTGTCCTCCGTCCCTGAAA
GCAGTTTCTATAGCAGCAGTGGCGGTGGCGGCTCCACAGGAAACATTCCTGCCTCGAATCCGAACCACCACCACCACCACCACCATCAGCAGCCCCCGGCACCCCCGCAGCCCGCCCCACCCCCGCCA
GGCTGCATTGTGTGCACGTCCTGTGGCTGCAGCGGCAGCTGCGGCTCGAGTGGCCTGACTGTCAGCTACGCCAACTACTTCCAGCACCCGTTCTCCGGTCCGTCCGTGTTCACCTTCCCCTTCTTGCC
CTTCAGTCCCATGTGCAGCAGCGGCTACGTCAGCGCCCAGCAGTACGGCGGCGGCTCCACCTTCCCCGTCGTGCACGCCCCTTACAGCAGCAGCGGGACCCCAGACCCTGTCCTGAGTGGGCAGTCCA
CGTTTGCCGTGCCACCCATGCAGAACTTCATGGCAGGGACAGCAGGGGTGTACCAGACCCAAGGACTGGTGGGCAGTAGCAATGGTTCCAGTCACAAAAAGAGCGGGAACCTATCTTGTTACAACTGC
GGGGCCACTGGTCACCGCGCCCAGGACTGCAAACAGCCGTCCATGGACTTCAACCGGCCAGGTAAGCGCGCGCCATGGCCGCGCCCACCAGGCTCCCGCAGGACCAGTGCACACAAATGCTTGGTTTT
TATGAAGAGTAAACTTCTTTCTTTGTAAAGCAAA

hide sequence

RefSeq Acc Id:

XM_054379872 ⟹ XP_054235847

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	16	93,482,298 - 93,563,941 (-)	NCBI

RefSeq Acc Id:

XM_054379873 ⟹ XP_054235848

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	16	93,482,298 - 93,536,716 (-)	NCBI

RefSeq Acc Id:

XR_008489065

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	16	93,477,129 - 93,563,941 (-)	NCBI

RefSeq Acc Id:

XR_243401

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	87,406,248 - 87,493,024 (-)	NCBI
GRCh37	16	87,439,852 - 87,525,870 (-)	NCBI

Sequence:

show sequence

AGGCCAACAACCCGGCCGACCTGGGCAGCCTCACCAACCTGACGGACGAGGTGGTGCGCAGCAA
GCTGCTGGTGTCGCTGGCGCTGCTGGGCTCGGAGCAGCGCGAGGCGGCGGGCGTGCTCTACCGCACGCTCACGCACATCGACTCCATCATCCACAACTACGGGCTGCAGCTTAACGAGGGCCGCACGG
GCGATGAGTTCCTGCTGCTGTTCACCATGGCCTCCAACCACCCGGCCTTCAGCTTCCACCAGAAGCAGGTGCTGCGCCAGGAGCTCACGCAGATCCAGAGCAGCCTGAACGGCGGCGGGGGCCACGGC
GGCAAGGGCGCGCCCGGGCCGGGCGGCGCGCTGCCCACTTGCCCAGCCTGCCACAAGATCACTCCAAGAACTGAGGCCCCTGTCAGCAGTGTCAGTAATAGTTTGGAGAATGCCCTGCACACATCAGC
ACATTCCACGGAGGAGTCGCTGCCCAAGAGGCCCTTAGGAAAACACAGCAAAGTGAGTGTTGAAAAGATAGACCTGAAGGGATTATCACACACAAAAAATGACAGAAATGTTGAATGTTCCTTTGAGG
TCTTGTGGTCTGATTCTTCAATAACATCAGTAACCAAATCTTCCTCTGAAGTGACGGAATTTATTTCAAAGCTATGTCAGCTCTATCCTGAAGAGAACTTGGAGAAACTCATTCCTTGCTTAGCTGGT
CCGGACGCATTTTATGTGGAGCGAAACCACGTGGATCTGGACTCAGGCCTGAGGTACCTGGCCTCATTACCTTCTCACGTGTTGAAAAATGACCATGTCAGGAGGTTTCTCAGCACTTCCTCTCCCCC
ACAGCAGCTTCAGAGTCCAAGTCCTGGCAATCCCTCCCTTTCTAAAGTAGGTACCGTGATGGGCGTGTCTGGAAGGCCTGTGTGTGGAGTGGCTGGTATCCCGTCCTCGCAGAGCGGAGCCCAGCACC
ACGGGCAGCACCCGGCCGGCTCCGCCGCCCCCTTGCCTCACTGCTCCCATGCGGGCAGCGCGGGCTCAGCCCTGGCCTACCGGACCCAGATGGACACATCACCTGCCATCCTCATGCCTTCCAGTCTG
CAGACCCCTCAGACCCAGGAGCAGAATGGGATTCTAGACTGGCTTAGGAAACTGCGTTTGCACAAGTATTACCCCGTCTTTAAGCAGCTCTCCATGGAGAAGTTTTTGAGCCTTACTGAAGAAGATCT
GAATAAATTTGAGTCTCTTACCATGGGGGCAAAGAAGAAGCTCAAGACCCAGCTGGAGCTGGAAAAGGAGAAGTCAGAGAGACGGTGCCTGAACCCCTCGGCCCCGCCGCTGGTCACCAGCAGTGGTG
TGGCTCGAGTGCCCCCCACCAGCCACGTCGGGCCCGTGCAGTCGGGGCGGGGCAGCCATGCAGCAGAGCTGCGGGTGGAAGTGGAGCAGCCCCATCACCAGCTGCCCCGGGAAGGCAGTTCCTCGGAG
TACTCCAGCTCCTCCTCCAGCCCCATGGGGGTACAGGCCCGGGAAGAGAGCTCCGACAGCGCTGAGGAGAATGACAGACGTGTGGAGATTCACTTGGAGAGCTCTGACAAGGAGAAGCCGGTGATGCT
GCTGAATCACTTCACTTCCAGTTCCGCCAGACCCACGGCCCAGGTTCTCCCTGTGCAGAATGAGGCCAGCTCCAATCCATCAGGCCACCACCCCCTGCCCCCGCAGATGCTGAGCGCAGCCTCACACA
TCACACCCATCCGCATGCTGAATTCCGTGCACAAGCCGGAAAGAGGGAGCGCGGACATGAAGCTCCTCTCGTCTTCTGTGCACTCACTTTTGTCTCTAGAAGAAAGGAATAAAGGATCTGGACCAAGA
AGCAGCATGAAAGTGGACAAGAGCTTTGGCAGCGCCATGATGGACGTGCTGCCCGCGTCCGCACCCCACCAGCCTGTGCAGGTCCTCTCTGGGCTTTCGGAGAGCAGCTCCATGTCACCCACAGTCTC
CTTTGGTCCCCGGACCAAAGTCGTGCATGCATCCACGCTGGACAGGGTGCTGAAGACAGCACAGCAACCGGCCCTGGTCGTGGAGACCAGCACGGCCGCCACGGGGACGCCCAGCACAGTCCTCCACG
CCGCCCGTCCGCCCATCAAACTGCTGCTGTCGTCATCTGTTCCTGCTGATTCTGCCATTTCTGGGCAAACTTCCTGTCCTAATAATGTGCAAATAAGTGTGCCCCCTGCAATAATAAACCCCCGGACT
GCTCTGTACACAGCCAACACCAAAGTTGCCTTTTCTGCAATGAGCAGTATGCCAGTGGGCCCCCTGCAGGGTGGCTTCTGTGCAAACAGCAACACTGCCTCTCCCAGCAGCCACCCCTCCACGTCCTT
TGCCAACATGGCCACGTTGCCCAGCTGCCCAGCCCCCAGCTCCAGCCCGGCGCTGTCCTCCGTCCCTGAAAGCAGTTTCTATAGCAGCAGTGGCGGTGGCGGCTCCACAGGAAACATTCCTGCCTCGA
ATCCGAACCACCACCACCACCACCACCATCAGCAGCCCCCGGCACCCCCGCAGCCCGCCCCACCCCCGCCAGGCTGCATTGTGTGCACGTCCTGTGGCTGCAGCGGCAGCTGCGGCTCGAGTGGCCTG
ACTGTCAGCTACGCCAACTACTTCCAGCACCCGTTCTCCGGTCCGTCCGTGTTCACCTTCCCCTTCTTGCCCTTCAGTCCCATGTGCAGCAGCGGCTACGTCAGCGCCCAGCAGTACGGCGGCGGCTC
CACCTTCCCCGTCGTGCACGCCCCTTACAGCAGCAGCGGGACCCCAGACCCTGTCCTGAGTGGGCAGTCCACGTTTGCCGTGCCACCCATGCAGAACTTCATGGCAGGGACAGCAGGGGTGTACCAGA
CCCAAGGACTGGTGGGCAGTAGCAATGGTTCCAGTCACAAAAAGAGCGGGAACCTATCTTGTTACAACTGCGGGGCCACTGGTCACCGCGCCCAGGACTGCAAACAGCCGTCCATGGACTTCAACCGG
CCAGGTACTTTTAGGTTGAAATACGCCCCTCCAGCAGAAAGTCTGGACTCCACAGATTGATATTTTTCTCTGGCAACAGAACGTTATTAAGCCATGGAGACATAAGGAAAATTAAATACAAAACTGAG
AAGTCTAGTTGCTGTTGAGCTTAATCTTTTTAATCCAAAGGTGCTTTACTTTTCCTAGACTGGATAGAAAATCTAGCGTAGAAGTGCATCAAACTCGATTTATTGCCAAAACCCTAGATTGGAGCTTG
GTGTCAGAACTCGCCTAGTGGGCATCTCTGTGGCTGGTGAGATCGGCCACCTCCACTTTTGGTTGCAGTGCAGAGACGCCATGTCTCCCGAAGAGCATTGCCATCACTGGCCCTCCTAGGCTCACACG
TCAATTCCAGGGCAGCTACACGTGGTCTGAATCGAGAACCGAGCTTGGAGTTCTCCAAGTGGAGTTCCACCCGCCGGACTCCTGACACCCCTGGGCTAGGGAAAATGTCGACTTTGTTTTGTTCTGTT
CCTAAAGTGATTAGCACTAATCTCTGGGATTTTTAAGGATTGCACTACAGAAGAATGTACCCTGATGTAAATCTCTGCGGTTCTGGGAGCCAAACTCCTCTGAGAACAGTCAGTGCAAGAGACTCCAA
TAATCCATATTGAAAGAGTCAGCACCAGCAGAGGCTACTCGACTTAGGACGCAACAGAGGTTTTAGTATTTCCTTCCCTCCTCCAAGCACTTGTAGCAGTTTCAGGTTTTTAATTTTTTTCTGCAAAT
AAATCTAAACTACGTTATTAAATAGAAATAGTTTACTCGCAACAACTTAATTTCTAAGGGTCCAAGTCCCAGAGAATCCATAGTCGTCAAAGCTTTGAGAGTATCTTTCTTCCCAGCCAGTCAGTGGC
TTTGAGCCCTATCTTCCACTACAAATGACCTCTCGAGGGGGGACGGCGACAGCGCGGCTCTGTGAGTGGCTGTGAGGATGCTGCACGTCCTCAGCAGAGTTTGCAAGTTGCTTTATCTCCCACGGGCT
CCCCAAGAACCTCCAACCCCGAGGCTTATCGCTAGCGGATTCACACCTGAGACAGACATTTCAACAATGATACAGTCCTGTCATTTATCAGCAAAAGATTGGGAATTTTCTCCTGTCAACTTCTTTTG
TATTAGGCTGTGTATTGATAGTTAATTCCGTTAAAAATTACTTGGAAAACAGTGGGAAGTGGTAGGACTCTGGAAGAGGCCACACACCCGAGAGCTGCGAGATCTGTGCAAGTCTGGTTTTGGTTAGG
TAGTAATAAAAGTCCTCACTGTAGATCTCTAAATTTCAACCCACGGAAATGAAAGCCTTTTGTCTGAAATTTACGGACTTAAATCTTCAAGGTTAAAGGGAATTTTCTGCTCAAATAATACTCTTATC
GAAAATGCTAAAGTCTTCAATGTTAAAATACTGATTGGTAAAATCTTGCAGTTGGGATTTTGCAGTTGGATATTTATTTTAAAAAAAATTATAATATTCAGACTATTCTTAAAATGGGACAATCAGCC
TCATGAAAAATTGATGTAAATCAGAAGAATACCCTAGAATGAGGCCTTGTGATGTGAGCGTTCAATTTGAAGAGCAGTTCCTAACTTCATAGAAACTAAAGCAGAAAGTTGTTACATTTTTTTTATGA
CAGGCTTTTAGTAGAATTTTTTAGTTTTATTTTAGTTGAATTTTATTTCTATGCAATGCAGAATTAACAGACCTCTTCTCCTCATGGTACACAGTATTACAGTGTTGAAGTAATGGTGATGCTTATTA
CAACAGCTATTTAGGGGAATGTTACGTTGATCTCTTAAATTGTAAACACTACAAAATGTCAAAATAATGAGAACTGACACAACTTTGCCTTAAAGAGTACTAGACTGGACCTTCTCATATTACGTTTA
AGGAAGACTTAGAGTGTTCATTGATGTTTACGATTTTAATATTTCTGAAGGCCATTACAGTGGCCTGGATATGTGCTGAAAGCCAAACTTTTAAATTTTTTGGTTTTTTTAAGCAAAGAAATATTTTA
AATAAATCCTATTTCAACACTGAAATTGTTGAAAACCGTCTCATAACAAAAGGAAAAAACATTGGAATTTTTGTTTTAGTGGTCAGTATAGGGGAATGAAAGCGTCTGTTGTTACCCACGTAACTATT
TTGATAAGTATTAGAGGTTAACCTTAAATCCAGCAAAACATTAAAACAGAAACTTTTCAACTTGGAGCCTGCCATTCAGCGTTGAGGTAGATGAGTTCCGACACTGTCACGGCTGTGTTCCCAGCAGC
GAAGGCCTCTGCGGAGCTGCCAGTCGTCTTGAACGTGCATGGGCGGCGTGTGACATCTCCAGGGAGGCCGTCCGAAGTCGAGAATCGTCAGCTGTAAGTAGGAGCTACACAGCGCAGAGAAAATGGAA
CCACCCATCCGTGAGGCCTCTTTCCGGAGGGAGCCGCACACTTGGACTTGAGAGTTTGCCAGCAGCGAGCTCGGATGCATCTCTCCAAAAGCCACCAAGGTCGGCGCGTCTGAAGAGCGTTTTGCGGT
CATCAGACTTCCTCATCTGAAAACACAGAACATACTGACCCTTTCAAGTACTTAGTCATTTTCCTGAAAGTGTGGTCTGTTTCAGAATGCTGTGGCAACCAGTGTTTTATTTTATGCCTTGCTCGTTG
TACATCATGATGACTGATGGTCTTCAAGGTTGTGAGGAAAGCCGTCTCCCTGCTTGACTCGACTGCTGTCCCAGAGGAGAGTCCTGTGCGACCTGAGCGGGGGTGGCTGCCATTTCCAGCATGCAGGT
GACTTCCAAAGAATGAGTCAGGTGGCACTGAAAGCCATGGGTTCTGAAGAGGCGAATTTGTTGAAAAGTCCCAAGGGTCTGAATGAAAGCATCTTTAATCAACACTCAACACTCGCAATATTCTAGAA
AACCATATACTGTGCTGGTTGAGGCCAAAGGTTAACATTGCTCCACTGTTCACCAAGGAAGGGGGCAGTGGCCATCCGCCGCGGCCTCACGTGCGTTGTAACAAGCCCTCATCACATGTGTGAGTCTT
ACGTGCACAAAAAGAGAAGGCTTTGGTACTGAAACTGGACACCTTGTGTACTCGATACCTTCACAGCTTCTATTGGACATATTTTCTTTTTAGGAATGAAGGAAAATTCTCCCATTTTTGAGCCATTC
TTTTGTCAATTCTACAAAATTGCATGTAACTTTATAAATATTTTTAAAAGATATAGTTTTGTAAATATTTAATATTCCGCTAATTTGATTTTGAATTGTAAATGTCAAGTATTCTGTTTTTGGGGTTT
TTATGTTTTATTATACTTTGTTAAAAAGGACAAATTGTACATTTTTAGAATGTTTTTATGAGTAAATTTAATGTACTGAAAATAAAAATTTTAAAAAAGGC

hide sequence


Protein RefSeqs	NP_055959	(Get FASTA)	NCBI Sequence Viewer
	XP_005255915	(Get FASTA)	NCBI Sequence Viewer
	XP_016878571	(Get FASTA)	NCBI Sequence Viewer
	XP_054235847	(Get FASTA)	NCBI Sequence Viewer
	XP_054235848	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAI01479	(Get FASTA)	NCBI Sequence Viewer
	BAA25505	(Get FASTA)	NCBI Sequence Viewer
	BAB83129	(Get FASTA)	NCBI Sequence Viewer
	BAF82371	(Get FASTA)	NCBI Sequence Viewer
	CAB55981	(Get FASTA)	NCBI Sequence Viewer
	EAW95388	(Get FASTA)	NCBI Sequence Viewer
	EAW95389	(Get FASTA)	NCBI Sequence Viewer
	EAW95390	(Get FASTA)	NCBI Sequence Viewer
	EAW95391	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000268616.4
	ENSP00000456499
	ENSP00000499622
GenBank Protein	Q8WYQ9	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_055959 ⟸ NM_015144

- UniProtKB:

A0A590UJW6 (UniProtKB/TrEMBL), A0A5F9XIK1 (UniProtKB/TrEMBL)

- Sequence:

show sequence

MASNHPAFSFHQKQVLRQELTQIQSSLNGGGGHGGKGAPGPGGALPTCPACHKITPRTEAPVSSVSNSLENALHTSAHSTEESLPKRPLGKHSKVSVEKIDLKGLSHTKNDRNVECSFEVLWSDSSIT
SVTKSSSEVTEFISKLCQLYPEENLEKLIPCLAGPDAFYVERNHVDLDSGLRYLASLPSHVLKNDHVRRFLSTSSPPQQLQSPSPGNPSLSKVGTVMGVSGRPVCGVAGIPSSQSGAQHHGQHPAGSA
APLPHCSHAGSAGSALAYRTQMDTSPAILMPSSLQTPQTQEQNGILDWLRKLRLHKYYPVFKQLSMEKFLSLTEEDLNKFESLTMGAKKKLKTQLELEKEKSERRCLNPSAPPLVTSSGVARVPPTSH
VGPVQSGRGSHAAELRVEVEQPHHQLPREGSSSEYSSSSSSPMGVQAREESSDSAEENDRRVEIHLESSDKEKPVMLLNHFTSSSARPTAQVLPVQNEASSNPSGHHPLPPQMLSAASHITPIRMLNS
VHKPERGSADMKLLSSSVHSLLSLEERNKGSGPRSSMKVDKSFGSAMMDVLPASAPHQPVQVLSGLSESSSMSPTVSFGPRTKVVHASTLDRVLKTAQQPALVVETSTAATGTPSTVLHAARPPIKLL
LSSSVPADSAISGQTSCPNNVQISVPPAIINPRTALYTANTKVAFSAMSSMPVGPLQGGFCANSNTASPSSHPSTSFANMATLPSCPAPSSSPALSSVPESSFYSSSGGGGSTGNIPASNPNHHHHHH
HQQPPAPPQPAPPPPGCIVCTSCGCSGSCGSSGLTVSYANYFQHPFSGPSVFTFPFLPFSPMCSSGYVSAQQYGGGSTFPVVHAPYSSSGTPDPVLSGQSTFAVPPMQNFMAGTAGVYQTQGLVGSSN
GSSHKKSGNLSCYNCGATGHRAQDCKQPSMDFNRPGTFRLKYAPPAESLDSTD

hide sequence

RefSeq Acc Id:	XP_005255915 ⟸ XM_005255858
- Peptide Label:	isoform X1
- UniProtKB:	A0A5F9XIK1 (UniProtKB/TrEMBL)
- Sequence:	show sequence MASNHPAFSFHQKQVLRQELTQIQSSLNGGGGHGGKGAPGPGGALPTCPACHKITPRTEAPVSS VSNSLENALHTSAHSTEESLPKRPLGKHSKVSVEKIDLKGLSHTKNDRNVECSFEVLWSDSSITSVTKSSSEVTEFISKLCQLYPEENLEKLIPCLAGPDAFYVERNHVDLDSGLRYLASLPSHVLKN DHVRRFLSTSSPPQQLQSPSPGNPSLSKVGTVMGVSGRPVCGVAGIPSSQSGAQHHGQHPAGSAAPLPHCSHAGSAGSALAYRTQMDTSPAILMPSSLQTPQTQEQNGILDWLRKLRLHKYYPVFKQL SMEKFLSLTEEDLNKFESLTMGAKKKLKTQLELEKEKSERRCLNPSAPPLVTSSGVARVPPTSHVGPVQSGRGSHAAELRVEVEQPHHQLPREGSSSEYSSSSSSPMGVQAREESSDSAEENDRRVEI HLESSDKEKPVMLLNHFTSSSARPTAQVLPVQNEASSNPSGHHPLPPQMLSAASHITPIRMLNSVHKPERGSADMKLLSSSVHSLLSLEERNKGSGPRSSMKVDKSFGSAMMDVLPASAPHQPVQVLS GLSESSSMSPTVSFGPRTKVVHASTLDRVLKTAQQPALVVETSTAATGTPSTVLHAARPPIKLLLSSSVPADSAISGQTSCPNNVQISVPPAIINPRTALYTANTKVAFSAMSSMPVGPLQGGFCANS NTASPSSHPSTSFANMATLPSCPAPSSSPALSSVPESSFYSSSGGGGSTGNIPASNPNHHHHHHHQQPPAPPQPAPPPPGCIVCTSCGCSGSCGSSGLTVSYANYFQHPFSGPSVFTFPFLPFSPMCS SGYVSAQQYGGGSTFPVVHAPYSSSGTPDPVLSGQSTFAVPPMQNFMAGTAGVYQTQGLVGSSNGSSHKKSGNLSCYNCGATGHRAQDCKQPSMDFNRPGKRAPWPRPPGSRRTSAHKCLVFMKSKLL SL hide sequence

RefSeq Acc Id:	XP_016878571 ⟸ XM_017023082
- Peptide Label:	isoform X2
- UniProtKB:	H3BS18 (UniProtKB/TrEMBL)
- Sequence:	show sequence MWKTKKKFLGKIYGGKQITPRTEAPVSSVSNSLENALHTSAHSTEESLPKRPLGKHSKVSVEKI DLKGLSHTKNDRNVECSFEVLWSDSSITSVTKSSSEVTEFISKLCQLYPEENLEKLIPCLAGPDAFYVERNHVDLDSGLRYLASLPSHVLKNDHVRRFLSTSSPPQQLQSPSPGNPSLSKVGTVMGVS GRPVCGVAGIPSSQSGAQHHGQHPAGSAAPLPHCSHAGSAGSALAYRTQMDTSPAILMPSSLQTPQTQEQNGILDWLRKLRLHKYYPVFKQLSMEKFLSLTEEDLNKFESLTMGAKKKLKTQLELEKE KSERRCLNPSAPPLVTSSGVARVPPTSHVGPVQSGRGSHAAELRVEVEQPHHQLPREGSSSEYSSSSSSPMGVQAREESSDSAEENDRRVEIHLESSDKEKPVMLLNHFTSSSARPTAQVLPVQNEAS SNPSGHHPLPPQMLSAASHITPIRMLNSVHKPERGSADMKLLSSSVHSLLSLEERNKGSGPRSSMKVDKSFGSAMMDVLPASAPHQPVQVLSGLSESSSMSPTVSFGPRTKVVHASTLDRVLKTAQQP ALVVETSTAATGTPSTVLHAARPPIKLLLSSSVPADSAISGQTSCPNNVQISVPPAIINPRTALYTANTKVAFSAMSSMPVGPLQGGFCANSNTASPSSHPSTSFANMATLPSCPAPSSSPALSSVPE SSFYSSSGGGGSTGNIPASNPNHHHHHHHQQPPAPPQPAPPPPGCIVCTSCGCSGSCGSSGLTVSYANYFQHPFSGPSVFTFPFLPFSPMCSSGYVSAQQYGGGSTFPVVHAPYSSSGTPDPVLSGQS TFAVPPMQNFMAGTAGVYQTQGLVGSSNGSSHKKSGNLSCYNCGATGHRAQDCKQPSMDFNRPGKRAPWPRPPGSRRTSAHKCLVFMKSKLLSL hide sequence

Ensembl Acc Id:

ENSP00000268616 ⟸ ENST00000268616

Ensembl Acc Id:

ENSP00000456499 ⟸ ENST00000561928

Protein Domains

CCHC-type

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q8WYQ9-F1-model_v2	AlphaFold	Q8WYQ9	1-949	view protein structure

RGD ID:

6793616

Promoter ID:

HG_KWN:24431

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, HeLa_S3, Lymphoblastoid, NB4

Transcripts:

OTTHUMT00000269107, UC002FKA.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	16	86,083,826 - 86,084,326 (-)	MPROMDB

RGD ID:

7233083

Promoter ID:

EPDNEW_H22286

Type:

initiation region

Name:

ZCCHC14_1

Description:

zinc finger CCHC-type containing 14

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H22287 EPDNEW_H22288

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	87,491,948 - 87,492,008	EPDNEW

RGD ID:

7233081

Promoter ID:

EPDNEW_H22287

Type:

initiation region

Name:

ZCCHC14_3

Description:

zinc finger CCHC-type containing 14

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H22286 EPDNEW_H22288

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	87,492,121 - 87,492,181	EPDNEW

RGD ID:

7233085

Promoter ID:

EPDNEW_H22288

Type:

initiation region

Name:

ZCCHC14_2

Description:

zinc finger CCHC-type containing 14

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H22287 EPDNEW_H22286

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	87,492,317 - 87,492,377	EPDNEW

Database	Acc Id	Source(s)
COSMIC	ZCCHC14	COSMIC
Ensembl Genes	ENSG00000140948	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000268616.9	UniProtKB/Swiss-Prot
	ENST00000561928	ENTREZGENE
	ENST00000671377	ENTREZGENE
Gene3D-CATH	1.10.150.50	UniProtKB/Swiss-Prot
	3.30.1520.10	UniProtKB/Swiss-Prot
	Zinc finger, CCHC-type	UniProtKB/Swiss-Prot
GTEx	ENSG00000140948	GTEx
HGNC ID	HGNC:24134	ENTREZGENE
Human Proteome Map	ZCCHC14	Human Proteome Map
InterPro	PX_dom_sf	UniProtKB/Swiss-Prot
	SAM	UniProtKB/Swiss-Prot
	SAM/pointed_sf	UniProtKB/Swiss-Prot
	ZCCH14_SAM	UniProtKB/Swiss-Prot
	ZCCHC14	UniProtKB/Swiss-Prot
	Znf_CCHC	UniProtKB/Swiss-Prot
	Znf_CCHC_sf	UniProtKB/Swiss-Prot
KEGG Report	hsa:23174	UniProtKB/Swiss-Prot
NCBI Gene	23174	ENTREZGENE
OMIM	620697	OMIM
PANTHER	PTHR16195	UniProtKB/Swiss-Prot
	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 14	UniProtKB/Swiss-Prot
Pfam	SAM_1	UniProtKB/Swiss-Prot
	zf-CCHC	UniProtKB/Swiss-Prot
PharmGKB	PA134895795	PharmGKB
PROSITE	ZF_CCHC	UniProtKB/Swiss-Prot
SMART	ZnF_C2HC	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF47769	UniProtKB/Swiss-Prot
	SSF57756	UniProtKB/Swiss-Prot
	SSF64268	UniProtKB/Swiss-Prot
UniProt	A0A590UJW6	ENTREZGENE, UniProtKB/TrEMBL
	A0A5F9XIK1	ENTREZGENE, UniProtKB/TrEMBL
	H3BS18	ENTREZGENE, UniProtKB/TrEMBL
	Q8WYQ9	ENTREZGENE, UniProtKB/Swiss-Prot
UniProt Secondary	D3DUN1	UniProtKB/Swiss-Prot
	O60324	UniProtKB/Swiss-Prot
	Q3MJD8	UniProtKB/Swiss-Prot
	Q9UFP0	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2016-02-16	ZCCHC14	zinc finger CCHC-type containing 14		zinc finger, CCHC domain containing 14	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Send us a Message

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD